Next Article in Journal
TRPV1 in Cardiovascular Disease: A Molecular Nexus of Treatment
Previous Article in Journal
(-)-Epicatechin Promotes Epigenetic and Metabolic Changes in an Obesity Model
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Alteration of Lipid Bilayer Electrical Potential by Phytochemicals and Synthetic Analogs: Implications for Cellular Function

by
Svetlana S. Efimova
1,
Quan Minh Pham
2,
Huong Thi Thu Trinh
2,
Long Quoc Pham
3,4 and
Olga S. Ostroumova
1,*
1
Institute of Cytology of Russian Academy of Science, Tikhoretsky Ave. 4, St. Petersburg 194064, Russia
2
Institute of Chemistry, Vietnamese Academic of Science and Technology (ICH, VAST), 18 Hoang Quoc Viet, Hanoi 113000, Vietnam
3
Laboratory of Biophysics, Institute for Advanced Study in Technology, Ton Duc Thang University, 19 Nguyen Huu Tho Street, Ho Chi Minh City 700000, Vietnam
4
Faculty of Pharmacy, Ton Duc Thang University, 19 Nguyen Huu Tho Street, Ho Chi Minh City 700000, Vietnam
*
Author to whom correspondence should be addressed.
Biomolecules 2026, 16(3), 342; https://doi.org/10.3390/biom16030342
Submission received: 9 January 2026 / Revised: 13 February 2026 / Accepted: 21 February 2026 / Published: 24 February 2026
(This article belongs to the Special Issue Botanic Metabolites: From Extraction to Application)

Abstract

Phytochemicals, including flavonoids, stilbenoids, alkaloids, terpenoids, and structurally related synthetic small molecules, exhibit a broad spectrum of beneficial pharmacological effects. These effects stem not only from interactions with specific protein targets but also from their capacity to modify the physical properties of biological membranes. A key membrane property influenced by these plant-derived compounds is the electrical potential drop at the membrane–water interface, which plays a crucial role in numerous cellular processes. Changes in membrane potential impact the function of embedded proteins and ion channels, thereby modulating cell signaling, transport, and pharmacological responses. This review compiles data on how diverse plant and synthetic small molecules alter membrane physical characteristics, particularly the dipole component of the boundary potential in lipid bilayers primarily composed of phosphatidylcholine, a predominant membrane lipid in mammals and fungi. In-depth analysis of structure–activity relationships in this context elucidates how various structural modifications affect the compounds’ ability to shift membrane electrical potential. Understanding these relationships can pinpoint molecular features that drive membrane interactions and facilitate the discovery and design of more potent dipole-modifying agents with therapeutic potential.

1. Introduction

1.1. Origin of Membrane Dipole Potential

Cell membranes act as semipermeable barriers, separating the intracellular space from external surroundings while maintaining cellular integrity and compartmentalization. They facilitate cellular processes, regulate interactions, and sustain the transmembrane electrochemical potential crucial for signal transduction. The selective transport of ions creates a charge imbalance, generating an electrical potential difference (Δφ) across the membrane, typically ranging from 10 to 100 mV [1]. This potential influences membrane proteins like voltage-gated Na+, K+, and Ca++ channels [2], and can be measured experimentally with electrodes [3,4].
Another type of electrostatic potential associated with membranes is the boundary potential, which consists of two primary components: the surface potential (φs) and the dipole potential (φd). Biological membranes typically contain 10–20% negatively charged lipids. For example, mammalian cell membranes include phosphatidylserine [5,6,7], while bacterial membranes are primarily made up of phosphatidylglycerol and cardiolipin [8,9,10,11]. Mitochondrial membranes and those of late endosomal compartments are also characterized by a significant concentration of negatively charged lipids [12,13]. The magnitude of φs, typically ranging in the tens of millivolts, is influenced by both the negative charges of membrane lipids and the degree to which these charges are neutralized by surrounding ions in the solution [1,14]. Due to the presence of negatively charged lipids in the membrane, φs facilitates the accumulation of cations near the membrane surface while reducing the concentration of anions [15]. Although measuring the exact value of φs is challenging, it can be approximated using the Gouy–Chapman–Stern model [16,17,18] or by determining the potential at the sliding plane, known as the electrokinetic potential (ζ) [18,19,20,21]. Numerous studies have addressed the impact of φs in ion transport processes, as outlined in a comprehensive review by Ermakov [22].
Regardless of membrane surface charge, the bilayer’s hydrophobic region has more positive potential compared to the surrounding solution, and this potential jump at the membrane boundary is called a dipole, φd [14,23,24,25,26,27]. It arises from the orientation of inherent lipid dipoles—particularly those from carbonyl groups and headgroups—along with the adjacent layer of water molecules at the lipid–water interface [28]. φd significantly increases permeability of phospholipid membranes to anions over cations, affecting protein conformation and function. Liberman and Topaly first proposed φd at the membrane/solution interface [29], while Chladky and Haydon provided experimental evidence in 1973 [30]. Later, Ketterer et al. [31] developed a model that incorporates the interaction potential energy of a hypothetical ion with both dipoles and membrane charges. Benz and co-authors introduced a generalized electrostatic potential profile that includes both φs and φd [32]. This approach remains relevant today.

1.2. Methods for Assessing the Membrane Dipole Potential

The magnitude of φd depends on the chemical structure of the lipids constituting the membrane [26,33,34,35,36,37]. Although the absolute value of the potential at the membrane/solution interface cannot be directly measured, it can be estimated using variety of methods and models (Figure 1).
The simplest method for quantitatively assessing the φd is the lipid monolayer technique [27,38,39]. The change in potential difference is measured after spreading a monolayer of lipid onto the surface of a Langmuir trough. It is crucial to note that the potential difference obtained through the monolayer technique for a given lipid composition significantly exceeds the values determined using methods involving planar lipid bilayers or lipid vesicles. Several factors may account for this discrepancy. These include the possibility that the φd values for the monolayer are overestimated, that the φd values for the bilayer are underestimated, or that the monolayer may not serve as a sufficiently accurate model to represent half of a bilayer [40]. The φd values of these two structures should not be directly compared. Therefore, in this review, all analyzed values were sourced from studies that conducted measurements using the bilayer techniques.
In terms of monitoring changes in the φd, a simple and reliable method is through the use of voltage-sensitive fluorescent probes incorporated into lipid vesicles [29,40,41,42,43,44,45,46]. A common assumption in estimating φd with fluorescent potential-sensitive dyes is that the dye itself does not influence the φd value. Moreover, this technique relies on calibration with other methodologies. Despite this, the method offers an undeniable advantage regarding its applicability to measure φd in cell membranes [47,48,49,50].
Planar lipid bilayers serve as the most practical model system for experimentally evaluating changes in φd caused by ions and small molecules. The most commonly used approaches with lipid bilayers include determination of Δφd from ion translocation rates [40], ionophore-induced conductance [40,51], the compensation for the intramembrane electric field [52,53], and molecular dynamics calculations [54,55,56,57,58,59,60]. A method used to determine the ratio between the conductances of a hydrophobic anion (tetraphenylborate) and cation (tetraphenylphosphonium or tetraphenylarsonium) is complex and not free from artifacts [61]. The method—based on the measurement of ionophore-induced conductance of lipid bilayers, initially applied by Andersen et al. [51] to investigate changes in φd influenced by the plant flavonoid phloretin—was later refined in subsequent research [62]. However, the conductance-based approach has limitations, including the assumption that its value remains unaffected by factors unrelated to the electrical potential distribution. For instance, this method overlooks the impact of membrane fluidity on the mobility of charged complexes, which could influence the results. The compensation method is particularly useful for analyzing the asymmetry in potential distribution resulting from the adsorption of charged particles or dipole-modifying substances that cannot permeate through the membrane [52].
Additionally, the literature data supports the use of dielectric spectroscopy, cryo-electron microscopy and atomic force microscopy as alternative approaches to estimate φd [63,64,65,66]. It is noteworthy that the φd value can vary considerably depending on the estimation technique employed.

2. Membrane Dipole Potential Significance

The φd is vital for cellular function, progressively decreasing along the secretory/endocytic pathway: plasma membrane >> lysosome > Golgi > endoplasmic reticulum. Mitochondrial membranes maintain slightly higher φd levels than lysosomes [67]. This suggests φd plays a key role in membrane recognition, assisting protein sorting and docking based on dipole moments. During the cell cycle, φd peaks in the G1 phase due to increased cholesterol, then declines by 8–10% in the S and G2/M phases as lipids reorganize for cell division. These shifts contribute to early-cycle hyperpolarization and mitotic depolarization, ensuring ion flux and protein interactions necessary for cell cycle progression. Cholesterol adjustments largely drive these changes, linking φd regulation to crucial proliferation checkpoints [50]. Studies also show oxidative stress in human erythrocytes significantly elevates φd levels [48]. Interestingly, natural antioxidants like flavonoids may reduce φd. Metabolic disorders, such as Smith–Lemli–Opitz syndrome, disrupt sterol biosynthesis and cause cholesterol precursor buildup, severely impacting φd. This highlights its importance in understanding disease mechanisms [68].
φd regulates ion transport rates across biological membranes, influencing the gating of hERG K+ channels, OmpF porin, and KcsA channels [69,70,71,72,73]. Its impact on the selectivity of KvAP and GluR channels, connexin 32 hemichannel, SecYEG bacterial channel, ion channel produced by Vpu protein of HIV-1, and CNGA2 channel can stem from interactions between polar groups, dipole motifs, and membrane electrostatic potential [74,75,76,77,78,79,80]. This also applies to model systems like gramicidin A, alamethicin, syringomycin E, surfactin, amphotericin B, cecropin A, polymyxin B, and nisin [81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96].
φd heavily impacts the function of various membrane proteins, such as receptor tyrosine kinases of ErbB family, ion pumps like Na+-K+-ATPase and Ca++-ATPase, phospholipases A2 and C, the serotonin 1A receptor, and the binding of the pre-sequence of cytochrome c oxidase subunit IV (p25) to membranes [41,49,59,97,98,99,100,101,102,103,104,105]. The inhibition of Na+-K+-ATPase by ether lipids [106] may result from higher φd in ether lipid membranes compared to ester ones [28]. Additionally, Clostridium perfringens α-toxin aggregation on membranes is linked to an increase in φd [107].
Localized variations in φd, particularly in cholesterol- and sphingolipid-rich membrane microdomains, may influence the function of specific peptides and proteins [55,108,109,110,111], including amyloid-β-peptides linked to Alzheimer’s disease [112]. Changes in membrane proteins due to lipid–protein interactions can be analyzed using φd as a sensitive marker. Additionally, φd measurements are useful for evaluating membrane protein purification, providing insights into dipolar environment shifts, protein function, and solubilization efficiency [113].
Extensive evidence highlights the role of φd in processes linked to viral activity. Elevated φd levels enhance bilayer stability by repelling cations necessary for hemifusion stalk formation, while modifiers reduce φd to facilitate processes such as viral entry or exocytosis [41]. The simian immunodeficiency virus fusion peptide interacts with membranes to influence φd, which in turn impacts the degree of membrane fusion induced by the peptide [114]. Cholesterol has been shown to strengthen the affinity of the HIV GP41 fusion peptide for model membranes, accelerating lipid mixing rates through its effects on φd [115]. Adjustments to φd have been reported to directly influence the binding affinity of HIV fusion peptides to membranes [59]. Similarly, the antiviral effectiveness of 25-hydroxycholesterol against HIV may be tied to alterations in lipid membrane properties, including changes in φd [116]. φd serves as a key modulator in interactions between the HIV protease inhibitor saquinavir and membranes [117]. Gp41-derived peptides, such as sifuvirtide, enfuvirtide, and T-1249, which inhibit HIV-1 fusion, show a reduction in φd for erythrocyte and lymphocyte membranes [118,119]. Additionally, a cholesterol-conjugated derivative of C34, an HIV-1 fusion inhibitor peptide, significantly decreases φd while enhancing the peptide’s antiviral potency via membrane interactions [120]. Peptides from the S2 domain of SARS-CoV (770–788 and 1185–1202), associated with the fusion peptide and pre-transmembrane domain, respectively, can also decrease φd [121]. These effects are strongly dependent on membrane lipid composition, and combinations of such peptides may create synergistic impacts. This implies that alterations in φd influence SARS-CoV’s fusion process. For SARS-CoV-2, ether phospholipids have been found to alter the conformation of its fusion peptide and influence its binding to hybrid membranes, indicating that φd may significantly impact its fusion mechanism as well [122]. The binding affinity of the hemagglutinin fusion peptide has been observed to increase with higher φd levels [59].
The interaction of drugs and biologically active substances with membranes depends on φd, and drugs by themselves also affect φd value [117,123]. φd regulates cell-penetrating peptide insertion into membranes [124] and inversely correlates with penetratin concentration in the cytoplasm [125,126]. Atorvastatin, an HMG-CoA reductase and cholesterol synthesis inhibitor, lowers φd [125]. Increased φd enhances bacitracin permeation [127], while antibiotic nisin significantly alters φd in negatively charged membranes [128]. Changes in φd may explain the antibacterial effects of polyalanine peptides [129]. Insecticide lindane, general and local anesthetics, and dexibuprofen-loaded nanoparticles also modulate φd [56,92,130,131,132,133,134,135,136,137]. Pregnanolone’s membrane partitioning is governed by φd [123]. Certain isoniazid derivatives reduce φd in membranes resembling Mycobacterium tuberculosis’s cell wall [138]. Natamycin binding and aggregation decrease φd [139]. Ru(III) complexes’ anticancer activity is linked to their lipid-specific dipole-modifying properties in normal and cancer cell membranes [140]. Procyanidin B3, picolinamide, verapamil, and arbutin lower φd [141,142,143,144], while φd changes impact piroxicam’s kinetics [145]. The antifungal activity of cationic gemini surfactants may stem from their dipole-modifying effect [146,147].
Literature findings indicate that φd can either inhibit or enhance the membrane insertion of amphiphilic antimicrobial peptides. This effect is contingent upon the orientation of the peptide’s hydrophobic dipole moment, positioning φd as a critical determinant of their antimicrobial efficacy alongside the surface charge of cellular membranes [59,148]. The dual regulation of surface charge and φd offers promising avenues for addressing microbial resistance mechanisms, particularly those linked to reductions in the negative surface charge. This can be achieved through the targeted modulation of the dipole component using small molecules.

3. Small Molecules to Disturb Membrane Dipole Potential

The investigation of the role of φd in diverse biological processes, alongside the quest for pharmacologically active compounds capable of enhancing the efficacy of various membranotropic drugs, has become an increasingly prominent area of focus within biology and pharmacology. Consequently, the continuous development and diversification of molecular tools—specifically, small molecules designed to facilitate precise and predictable modifications of the φd—remains a critical objective in advancing this field.
In general, φd is related to the dipole moment of lipids, their packing density in the bilayer, and the membrane dielectric constant, as described by the Helmholtz equation for a planar capacitor [23,24,36]. It is believed that the incorporation of small molecules affects the dipole moment of lipids by virtue of the fact that they possess their own dipole moments in lipid bilayers, by alteration of membrane hydration, as well as by changing the surface density of dipoles [14,51,149,150,151,152,153]. A strong dependence of the φd on lipid packing stress and vice versa should also be taken into account [154,155,156].
Understanding how small molecules influence lipid membranes and their link to pharmacological activity is crucial for creating new drugs, particularly natural compounds targeting cell membranes directly to minimize drug resistance.
This review summarizes the available information about the modulation in the φd of lipid bilayers composed of phosphatidylcholines caused by small molecules of a different chemical nature. Phosphatidylcholines were chosen as an abundant membrane lipid species in eukaryotic cells [157,158].

3.1. Polyphenolic Compounds

Over 8000 different phenolic compounds have been identified, with new discoveries adding to this number each year [159,160]. Flavonoids and stilbenes are often studied in the context of drug discovery [161,162,163]. Findings from both preclinical and clinical studies reinforce the protective role of polyphenols in aging cells [164,165], cardiovascular [166], neurodegenerative [167], and oncological diseases [168]. This beneficial effect is largely attributed to their potent antioxidant properties, which stem from the presence of numerous hydroxyl groups. The broad and detailed classification of flavonoids highlights their remarkable structural and functional diversity. This underscores the importance of investigating the functional characteristics of flavonoids and identifying the key structural components that drive specific biological activities.
Figure 2 presents a summary of literature findings regarding the dipole-modifying capacity of polyphenols. It illustrates how the compounds influence φd of membranes composed of phosphatidylcholines. A correlation analysis using octanol/water partition coefficients (logD) and dipole moment values (μ), as presented in the relevant cited sources, shows no correlation between |Δφd| and logD for polyphenols (Spearman’s rank correlation coefficient is equal to 0.1). At the same time, a significant correlation exists between |Δφd| and dipole moment (μ) values (correlation coefficient is equal to 0.5).
Figure 2. The action of various polyphenols on the dipole potential of phosphocholine membranes is explored. The mean maximum changes in the dipole potential (Δφd) are taken from [14,51,93,149,150,153,169,170,171]. * The estimated Δφd value in the presence of phloretin is derived by consolidating and averaging data from [14,51,149,150]. The deviation from the mean Δφd value observed in experiments is presented as an error bar, and it is taken from the corresponding reference for a given compound or represents the maximum difference between mean Δφd values from different cited studies. The column color depends on the strength of the dipole-modifying ability of the compound: pink—slight increase in φd (20 ≤ Δφd < 60 mV), black—negligible effect on φd (|Δφd| < 20 mV), cyan—slight decrease in φd (−20 ≥ Δφd > −60 mV), blue—moderate dipole-modifying efficiency (−60 ≥ Δφd > −100 mV), and dark blue—significant decrease in φd (Δφd ≤ −100 mV).
Figure 2. The action of various polyphenols on the dipole potential of phosphocholine membranes is explored. The mean maximum changes in the dipole potential (Δφd) are taken from [14,51,93,149,150,153,169,170,171]. * The estimated Δφd value in the presence of phloretin is derived by consolidating and averaging data from [14,51,149,150]. The deviation from the mean Δφd value observed in experiments is presented as an error bar, and it is taken from the corresponding reference for a given compound or represents the maximum difference between mean Δφd values from different cited studies. The column color depends on the strength of the dipole-modifying ability of the compound: pink—slight increase in φd (20 ≤ Δφd < 60 mV), black—negligible effect on φd (|Δφd| < 20 mV), cyan—slight decrease in φd (−20 ≥ Δφd > −60 mV), blue—moderate dipole-modifying efficiency (−60 ≥ Δφd > −100 mV), and dark blue—significant decrease in φd (Δφd ≤ −100 mV).
Biomolecules 16 00342 g002
By analyzing the chemical structures of polyphenols, especially those closely related as structural analogs, alongside the magnitude of changes that they induce in the φd, the following patterns were observed:
(1) The closing of a heterocycle in the naringenin molecule compared to phloretin leads to a decrease in the molecule’s dipole-modifying ability by 75 mV due to a reduction in both the magnitude of μ (by about 2 D) and logD (by more than 1) (Figure 3a). Therefore, the key factors responsible for the observed effects are the molecule’s polarity and hydrophobicity.
(2) Methylation of the hydroxyl group at the 4′-position of the B-ring in biochanin A compared to genistein leads to a significant increase in the dipole-modifying ability, although μ and logD values of the isoflavones are close (Figure 3b). More probably, this modification affects the molecule’s orientation, causing the dipole moment of biochanin A to align more parallel to the normal than to the membrane surface. The assumption that not only the magnitude but also the orientation of μ in the membrane plays a key role aligns well with the existing data [172].
(3) Glycosylation at the 6′-position of the A-ring, 3-position of the C-ring and 7-position of the A-ring of phloretin, quercetin, and genistein, respectively, results in a significant decrease in logD value (by 1.7–3) and consequently in dipole-modifying ability (by about 60 mV). In the case of chalcones and flavonols, the effect may also be attributed to differences in polarity between the glycosylated and nonglycosylated forms (by about 1.5–2 D) (Figure 3c).
(4) The hydrogenation of a double bond in the heterocycle of flavonol quercetin to obtain flavanonol taxifolin leads to a significant reduction in μ (by about 2 D) and loss of dipole-modifying ability, indicating that molecular polarity is a key factor (Figure 3d). In contrast, the same modification with flavone apigenin to get flavanone naringenin, compared to the other, also causes a similar decrease in μ but does not affect the Δφd value (Figure 3d). This difference may be attributed to the influence of the presence/absence of the hydroxyl group in the 3-position on the orientation of the flavonoid molecules within the lipid bilayer.
(5) Stilbenes, such as resveratrol and piceatannol, whose polyphenol rings are connected by a hydrocarbon linker lacking heteroatoms, generally do not exhibit the ability to affect the φd independently of the number of hydroxyl groups. This is likely due to their relatively low μ, suggesting that the polarity of polyphenol molecules is markedly determined by the degree of oxidation of the linker between the rings (Figure 3e).
(6) An additional hydroxyl group at the 5-position of the A-ring in the isoflavone genistein compared to daidzein leads to an increase in μ (by 1.7 D) and |Δφd| value (by 50 mV). In contrast, the same modification in the flavanones liquiritigenin and naringenin resulting in an increased μ (by about 1 D) does not enhance the dipole-modifying ability. These findings highlight the crucial role of molecular orientation in the lipid bilayer affected by the double bond in the heterocycle or the position of the B-ring (Figure 3f).
(7) The additional hydroxyl group at the 5′-position of the B-ring in myricetin compared to quercetin slightly increases μ but decreases logD, which results in similar dipole-modifying ability of the flavonols (Figure 3g).
Figure 3. The relationship between the chemical structure of polyphenols and their dipole-modifying ability: (a) phloretin and naringenin; (b) genistein and biochanin A; (c) phloretin and phlorizin, quercetin and rutin, genistein and genistin; (d) quercetin and taxifolin, apigenin and naringenin; (e) resveratrol and piceatannol; (f) daidzein and genistein, liquiritigenin and naringenin; (g) quercetin and myricetin; (h) chrysin and baicalein, apigenin and scutellarein, apegenin and luteolin; (i) 4′-hydroxychalcone and 2′-hydroxychalcone, 2-chloro-2′-hydroxychalcone and 3-chloro-2′-hydroxychalcone, 4-chloro-2′-hydroxychalcone and 5′-chloro-2′-hydroxychalcone. The logD, μ, and Δφd values are presented according to [93,149,153,169,170,173]. Abbreviations: logD—the value of the logarithm of the octanol/water partition coefficient at pH 7.4; μ—molecular dipole moment; Δφd(max)—the maximum changes in the dipole potential of neutral membranes enriched with phosphatidylcholine (detailed information about the fatty acid composition of membrane-forming lipid and the method of Δφd estimation can be found in the relevant references [93,149,153,169,170].
Figure 3. The relationship between the chemical structure of polyphenols and their dipole-modifying ability: (a) phloretin and naringenin; (b) genistein and biochanin A; (c) phloretin and phlorizin, quercetin and rutin, genistein and genistin; (d) quercetin and taxifolin, apigenin and naringenin; (e) resveratrol and piceatannol; (f) daidzein and genistein, liquiritigenin and naringenin; (g) quercetin and myricetin; (h) chrysin and baicalein, apigenin and scutellarein, apegenin and luteolin; (i) 4′-hydroxychalcone and 2′-hydroxychalcone, 2-chloro-2′-hydroxychalcone and 3-chloro-2′-hydroxychalcone, 4-chloro-2′-hydroxychalcone and 5′-chloro-2′-hydroxychalcone. The logD, μ, and Δφd values are presented according to [93,149,153,169,170,173]. Abbreviations: logD—the value of the logarithm of the octanol/water partition coefficient at pH 7.4; μ—molecular dipole moment; Δφd(max)—the maximum changes in the dipole potential of neutral membranes enriched with phosphatidylcholine (detailed information about the fatty acid composition of membrane-forming lipid and the method of Δφd estimation can be found in the relevant references [93,149,153,169,170].
Biomolecules 16 00342 g003
(8) Flavones chrysin and baicalein, which are similar in structure, lipophilicity, and μ, differ by a hydroxyl group at the 6-position of the A-ring and exhibit opposite effects in terms of the φd value: baicalein increases φd, while chrysin decreases it (Figure 3h). Baicalein and scutellarein, which differ in one hydroxyl group at the 4′-position of the B-ring, also demonstrate opposite effects in terms of φd (Figure 3h). These observations suggest that the key factor influencing the dipole-modifying ability of flavones is the orientation of their dipole moments within the membrane. A similar modification of apigenin to obtain scutellarein results in a significant decrease in logD, but not dipole-modifying ability, which also indicates the dependence of the orientation of the molecule in the bilayer on the number and localization of hydroxyl groups in the flavone structure (Figure 3h). Hydroxylation at the 5′-position of the B-ring of apigenin to get luteolin leads to a decrease in μ (by about 1 D) and logD value (by 1.7) but an increase in dipole-modifying activity, which also indicates the predominance of orientation of flavones in the membrane over their polarity and hydrophobicity (Figure 3h).
(9) A hydroxyl group at the 2′-position of the A-ring of chalcone is more preferential than at the 4′-position, while the localization of the chlorine atom does not matter (Figure 3i).
The biological activities of flavonoids and stilbenes are closely associated with their specific interactions with cell membranes. These compounds act as prominent modulators of various ion transport systems, including KCNQ channels [174], hERG channel [175], Na+-K+-2Cl cotransporter 1 [176], different subtypes of the voltage-dependent (KV) K+-channels [177], Ca++-activated K+ channels [178,179], ATP-sensitive K+ channels [180], voltage-gated Na+ channels [181], cystic fibrosis transmembrane conductance regulator [182], α1β1γ2s GABAA and ρ1 GABAC receptors [183] and others. Through these modulatory functions, flavonoids and stilbenes exhibit significant therapeutic potential in treating conditions such as cardiovascular diseases, cancer, and cystic fibrosis. Additionally, the deep localization of polyphenols within membranes is known to greatly influence their effectiveness in combating diseases like cancer and neurodegenerative disorders [184,185].
Phloretin potentiates a lot of membranotropic antimicrobial agents by reducing φd [81,83,89,91,93,95,96]. The ability of butein, naringenin, cardamonin, 4′-hydroxychalcone, licochalcone A, and liquiritigenin to decrease the conductance of single ion channels produced by the antifungal cyclic lipopeptide syringomycin E was in agreement with their effects on φd of the lipid bilayers [93]. Chlorination of hydroxychalcone B-ring potentiates the ability of compound to diminish φd and improves its antimicrobial, antibiofilm, and antiproliferative activities, especially against aggressive breast cancer cell lines, leading to the consideration that the disturbance of the φd might have a main role in the implementation of biological action [169]. Protective effect of polyphenols from field horsetail extract on erythrocytes is believed to be attributed to the reduction of φd of cell membranes [186]. Anti-atherosclerotic activity of naringenin and naringin dihydrochalcone on blood cells might be related to their ability to reduce φd [187].

3.2. Thyroid Hormones and Xanthene Dyes

Thyroid hormones and xanthene dyes, though fundamentally distinct in their nature and functions, share a remarkable structural similarity: both consist of hydroxylated and halogenated benzene rings connected via an oxygen atom. Thyroid hormones, such as thyroxine and triiodothyronine, are iodinated derivatives of thyronine, whose core structure features two benzene rings bridged by an oxygen atom. These hormones primarily differ in the number of halogen substituents attached to their base structure. In contrast, xanthene dyes are synthetic compounds characterized by a three-ring system, where two benzene rings are joined by an oxygen-containing heterocyclic ring. Their structure also includes a benzoic acid group that forms a lactone ring with the xanthene core. Among these dyes, fluorescein stands out as a key representative; it undergoes halogenation to produce various derivatives. Xanthene dyes are widely used in medical applications due to their chromatic properties. Fluorescein, for example, plays a critical role in ophthalmology, where it is applied topically to assess corneal damage [188]. Similarly, Rose Bengal is utilized in the evaluation of liver function, showcasing the diverse clinical applications of these compounds [189]. The inclusion of halogen atoms significantly impacts the electron density within the benzene rings, thereby modifying the molecules’ dipole moments.
Figure 4 presents a summary of literature findings regarding the dipole-modifying capacity of thyroid hormones and xanthene dyes. There is a strong correlation between |Δφd| and μ, and |Δφd| and logD values for xanthene dyes (Spearman’s rank correlation coefficient is equal to 0.8 and 0.5 respectively). Similar to polyphenols, this might be associated with embedment of xanthene dyes dipoles into membrane.
Tetraiodothyronine, which contains an additional iodine atom compared to triiodothyronine, exhibits a lower μ but higher lipophilicity, factors that likely account for the small differences observed in the dipole-modifying activity of these molecules (Figure 5a).
The dipole-modifying effect of fluorescein derivatives is determined by the polarity of their molecules and depends on the type of halogen substituents introduced into the fluorescein structure. Iodinated derivatives, such as erythrosine and Rose Bengal, exhibit a stronger ability to reduce φd compared to brominated derivatives like eosin Y and phloxin B, respectively (Figure 5b). The presence of a tetrachlorobenzene moiety significantly enhances dipole-modifying ability; thus, phloxin B is capable of reducing φd, whereas eosin Y lacks this effect, and Rose Bengal has a more pronounced effect than erythrosine (Figure 5b).
The integrin αvβ3 on the plasma membrane and the truncated nuclear receptor TRα1 (p28) in the inner mitochondrial membrane act as thyroid hormone receptors, initiating their non-genomic effects [191]. Studies show triiodothyronine increases inward rectifier K+-channel activity by increasing their open probability, likely contributing to shorter action potential duration in hyperthyroidism [192]. Additionally, thyroid hormones’ activation of the Na+/H+ exchanger and Ca++-ATPase may explain their neuroprotective effects [193]. It is hypothesized that thyroid hormones induce a general disturbance in transmembrane dipolar organization, which could represent a fundamental aspect of their non-genomic mechanisms [194].
Upon photoirradiation, xanthene dyes, particularly Rose Bengal, phloxine B, erythrosine B, and eosin Y, have been demonstrated to induce K+ leakage from Staphylococcus aureus cells and cause dissipation of the membrane potential. These effects are primarily attributed to the production of reactive oxygen species [195]. Interestingly, while both thyroid hormones and xanthene dyes lead to a reduction in φd, they influence syringomycin E ion channels through distinct mechanisms. Thyroid hormones, such as thyroxine and triiodothyronine, exert their effects primarily by altering membrane elasticity, whereas Rose Bengal, phloxine B, and erythrosine influence the ion channels by affecting the bilayer electrostatics [94].

3.3. Saponins and Sapogenins

Saponins’ structural diversity underpins their physico-chemical, biological, and pharmacological properties, making them valuable in food, cosmetics, and pharmaceuticals [196]. They possess various effects, including anti-inflammatory, antipyretic, anti-nociceptive, anticancer, and anti-allergic activities [197]. Their hemolytic activity arises from interactions with cholesterol in erythrocyte membranes [198]. Saponins also play a key role as adjuvants in vaccine production [199,200,201]. Research highlights certain types—ginsenosides and diosgenins—as potential chemopreventive agents, and saikosaponins, glycyrrhizins, cycloartanes, dammaranes, oleananes, spirostanes, and furostanes for their anticancer potential [202,203,204,205,206].
Figure 6 summarizes literature findings on the dipole-modifying properties of saponins and related compounds. It illustrates the impact of these compounds on the φd of phosphatidylcholine bilayers and includes a correlation map linking their potential-modifying ability to the μ or logD values. Only glycosylated saponins, such as digitonin, tribulosin, dioscin, and escin, exhibit a moderate ability to influence φd. In contrast, all sapogenins, including diosgenin, uvaol, lupeol, and betulin, regardless of whether their core structure is steroidal or triterpenoid, do not affect φd (Figure 6). This indicates the significance of saponin’s ability to interact with water molecules absorbed onto the membrane. This fact is consistent with an absence of correlation between |Δφd| and μ-values and a significant correlation between Δφd and logD of saponins (Spearman’s rank correlation coefficient is equal to 0.1 and −0.7 respectively).
Also, this shows that pyridine derivatives of betulin have more pronounced effects on φd value compared to betulin (Figure 7). Taking into account a decrease in logD (by about 3) and the high dipole moment of the pyridine moiety (2.26 D), we can hypothesize that the observed increase in dipole-modifying ability is related to an increase in molecular polarity.
Saponins have the ability to physically extract cholesterol from cell membranes, particularly from lipid rafts, which play a vital role in functioning of various ion channels and cell signaling. The depletion of cholesterol caused by saponins can indirectly influence other crucial membrane lipids, such as phosphatidylinositol 4,5-bisphosphate (PIP2) [208], for example, resulting in the inhibition of BKCa channels [209]. Ginsenoside-Rd, a glycosylated saponin, appears to prevent the progression of atherosclerosis, likely through the inhibition of voltage-independent Ca++ channels [210].

3.4. Alkaloids and Related Antibacterial Compounds

Plant alkaloids have been found to exhibit various effects, including vasodilatory, antihypertensive, antiarrhythmic, anesthetic, and analgesic properties [211,212]. Additionally, some alkaloids demonstrate antiproliferative, antibacterial, and antioxidant activities [213]. Given the amphiphilic nature of most of alkaloids, it is hypothesized that one potential mechanism of their action involves interactions with lipid cell membranes.
Figure 8 summarizes available literature findings on the dipole-modifying ability of various alkaloids and nitrogen-containing antibiotics.
By examining the chemical structures of alkaloids and related compounds, particularly those that are structurally analogous, alongside the magnitude of changes they induce in φd, certain patterns have been identified.
(1) A moderate correlation exists between |Δφd| and μ for xanthines (Spearman’s rank correlation coefficient is equal to 0.4), likely due to these molecules integrating their dipoles into lipid bilayers, despite their relatively low logD values (about −1–0). The absence of a methyl group at the 3-position of 1,7-dimethylxanthine compared to caffeine does not affect the μ value although it is accompanied by an increase in dipole-modifying ability (by 20 mV) (Figure 9a). At the same time, the absence of the CH3-group at the 7-position of theophylline compared to caffeine leads to a significant increase in the μ-value (by more than 3 D) and the |Δφd| value (by 40 mV) (Figure 9a). An addition of isobutyl moiety to 1,3-dimethylxanthine results in a slight increase in dipole moment compared to theophylline but a minor reduction in dipole-modifying ability (Figure 9a). Unlike 7-(β-hydroxyethyl)theophylline, which is not characterized by a larger μ than caffeine, the oxohexyl radical at the 1-position of pentoxifylline increases the polarity but not the dipole-modifying ability of the molecule compared to caffeine (Figure 9a). All these observations indicate that the orientation of the dipole moment of the xanthine molecule in the membrane is more important than its absolute value.
(2) The pronounced ability of benzylamine protoalkaloids capsaicin and dihydrocapsaicin to reduce the φd is attributed to their high lipophilicity and polarity (Figure 9b). A hydrogenation of a double bond in the side chain of dihydrocapsaicin compared to capsaicin does not influence its dipole-modifying due to branching at the end of the “tail” of both molecules, which should have a disordering effect on the lipid bilayer and consequently decrease the dipole density.
(3) Fusidic acid derivatives with promising antibacterial activity, presented in Figure 9c, reduce the membrane boundary potential by approximately 30–40 mV, which is likely related to their relatively high μ values (about 4 D).
(4) The incorporation of decanoyl, phenoxybenzylidene, or phenoxybenzyl radical into the well-known antituberculosis antibiotic isoniazid structure results in the enlargement of both µ (by 7–16 D) and logD value (by about 4), thereby promoting the ability of molecules to penetrate membranes and exhibit their dipole-modifying properties (Figure 9d).
The literature indicates that alkaloids affect ion channels via lipid-mediated actions [215,216,217,218]. Capsaicin reduces membrane rigidity, influencing voltage-gated Na+ channels, ASIC1a, ASIC3, ENaC, P2x2, and GABA receptors [215,216,217,218]. Similar effects are noted on MscL, Kv2.1, and NaV channels [216]. Capsaicin impact Kv2.1 gating via alterations in the physicochemical properties of the membrane [219]. It also alters channels like CFTR, BK/Maxi-K, TRP, and L-type Ca++ channels by modifying the lipid matrix rather than directly interacting with proteins [216]. These findings emphasize alkaloids’ role in altering membrane elasticity and suggest they may regulate ion channels via transmembrane electrical potential changes, as seen with some antimicrobial agents [95,96,151].

3.5. Anesthetics

Local anesthetics have been utilized for several decades, yet their exact molecular mechanisms of action continue to be a subject of scientific inquiry. It is generally recognized that their analgesic effect is achieved by inhibiting voltage-gated Na+ channels in nerve fibers [220]. To accomplish this, local anesthetics must penetrate the plasma membrane and bind to specific sites located within the inner part of the channels [221,222,223]. Furthermore, the correlation between the lipid–water partition coefficients of the anesthetics and their ability to interact with membrane lipids indicates that membrane lipids themselves may serve as key targets, potentially enhancing the drugs’ clinical efficacy [224]. Although general anesthetics have been used in surgical practice for over 150 years, their precise molecular mechanism remains largely unclear. It is widely accepted that the anesthetic effect is primarily linked to the membrane-mediated action of these drugs on ion channels, such as GABAA receptors and K2P channels [225].
Figure 10 presents a summary of literature findings regarding the dipole-modifying capacity of local and general anesthetics.
A correlation exists between the chemical structures of amino esters and their ability to modify dipole potential. Longer hydrocarbon side chains, as seen in tetracaine versus procaine (Figure 10b), enhance membrane dipole potential due to tetracaine’s greater hydrophobicity. This aligns with studies where molecular dynamics simulations show deeper tetracaine integration into the lipid bilayer compared to procaine [226]. However, molecular dynamics simulations examining lidocaine’s effects on φd diverge from electrophysiological data probably due to differences in experimental design. Simulations use short durations and insert molecules into the membrane, whereas in vitro studies add compounds to the surrounding solution. Consequently, bilayer concentrations are lower in vitro, and higher small molecule levels may increase their effects.
Tetracaine stands out as one of the uncommon dipole modifiers with the ability to markedly enhance membrane dipole potential. Combining tetracaine with dipole-reducing compounds provides an opportunity to investigate contrasting dipole-modifying effects, particularly in research focused on the regulation of pore-forming activities of antimicrobial agents. This highlights the significance of tetracaine as a valuable molecular tool.
Substitution of the bromine at the 2-position in halothane for the difluoromethoxy-group in isoflurane, or changing the localization of chlorine and fluorines between the 1- and 2-carbons in the ethane fragment (isoflurane versus enflurane) does not practically affect the dipole-modifying ability (Figure 10b).
Taking into account the diminishing in φd by general anesthetics might provide missing pieces of the puzzle in the membrane theory of general anesthesia [133].

3.6. Phosphodiesterase Type 5 Inhibitors

Benzenesulfamide derivatives, such as sildenafil and vardenafil, along with benzodioxolyl compounds like tadalafil, are well-known phosphodiesterase type 5 inhibitors used in treatment of erectile dysfunction [227]. These inhibitors primarily promote smooth muscle relaxation by facilitating the accumulation of cyclic guanosine monophosphate (cGMP). By blocking phosphodiesterase type 5 activity, cGMP levels rise, initiating a chain reaction through the activation of protein kinase G and lowering calcium concentrations. This process ultimately results in significant muscle relaxation [228].
Figure 11a provides a comprehensive summary of findings from the literature concerning the ability of benzenesulfamide and benzodioxolyl derivatives to modify the dipole properties of phosphatidylcholine membranes.
Sildenafil and vardenafil reduce the φd by a comparable amount (70–80 mV), even though vardenafil has a considerably larger μ (by approximately 7 D) compared to sildenafil (Figure 11b). This suggests that the additional methyl group attached to the piperazine ring plays a significant role in influencing the molecule’s orientation within the lipid bilayer. To gain a clearer understanding of the relationship between the dipole-modifying effects of phosphodiesterase type 5 inhibitors and specific pharmacophore groups within these molecules, it is essential to investigate the membrane interactions of other compounds from this class of drugs.
The data collected permits the conclusion that, aside from the established mechanism of action characterized by smooth muscle relaxation through the accumulation of cyclic guanosine monophosphate (cGMP) [230], an alternative mechanism may be hypothesized for benzenesulfamide and benzodioxolyl derivatives. This alternative mechanism is proposed to involve their interaction with the lipid matrix of cellular membranes, enhancing the permeability for nitric oxide [231]. Increased nitric oxide diffusion subsequently stimulates guanylate cyclase activity, facilitating the conversion of guanosine triphosphate into cGMP [232].

3.7. Styryl Dyes

Styryl dyes, featuring a polymethine chromophore with conjugated double bonds, are rapid potential-sensitive membrane dyes [233]. Their optical response occurs within milliseconds, with fluorescence intensity and spectral profile influenced by transmembrane electric fields [234,235,236,237]. Styryl dyes are valuable for monitoring membrane-related processes in excitable cells [238]. However, while their spectral properties are well-documented, their interaction mechanisms with biological membranes remain unclear. A key limitation is the potential for these nanosensors to disrupt electrical charge distribution in the bilayer.
Figure 12a presents a summary of literature findings regarding the dipole-modifying capacity of styryl dyes in phosphatidylcholine membranes.
The ability to enhance the φd diminishes in the order RH 421 > RH 237 ≈ RH 160. The dipole moment of these dyes is formed by a negatively charged sulpho-group located at the membrane–water interface and a positive charge, which is distributed in a chromophore [240]. It is interesting that the increase in the length of the linker between two aromatic rings in RH 237 compared to RH 160 does not produce noticeable changes in the |Δφd| value likely due to the simultaneous increase in μ and decrease in logD (Figure 12b). An increase in the length of side chains in RH 421 compared to RH 160 significantly increases the dipole-modifying ability of the dye (by 80 mV), probably due to a higher logD value (by about 1) (Figure 12b).
The available literature emphasizes the need to reassess cell biology methodologies involving RH-series styryl dyes as potential-sensitive probes [241]. Due to the structural similarity between RH-series styryl dyes and ANEP, there arises a critical question regarding the feasibility of utilizing ANEP-based probes for such applications.

3.8. Chromonylallylmorpholine Derivatives

Research indicates that chromone-containing allylmorpholines exhibit strong selectivity for AChE and moderate antagonistic activity toward NMDA receptors [242], highlighting their potential as effective treatments for neurodegenerative conditions. Although the lipophilicity of these molecules is influenced by their functional groups, the morpholine ring itself contributes an optimal balance between lipophilic and hydrophilic properties, alongside drug-like characteristics favorable for therapeutic development [243].
Figure 13 illustrates how chromonylallylmorpholines influence φd of membranes composed of phosphatidylcholines and also provide the correlation map between their potential-modifying ability and μ/logD values of modifier molecules.
There is a significant correlation between |Δφd| and μ for chromonylallylmorpholines (Spearman’s rank correlation coefficient is about 0.5), which can be explained by the hypothesis that these molecules influence φd through their dipoles interacting with lipid bilayers, but at similar μ values, an increase in the length of the straight side chain (from 2 to 8 carbonyl atoms) or branched chain (from isopropyl to diethyl methyl) in the series of chromonylallylmorpholines is accompanied by an expected increase in logD and an unexpected decrease in dipole-modifying ability (by 70 and 60 mV, respectively) (Figure 14a). Moreover, there is a significant inverse correlation between Δφd and logD values of chromonylallylmorpholines (correlation coefficient is equal to −0.5). Probably, the elongation of the hydrophobic radical contributes to a decrease in the projection of μ onto the normal to the membrane surface.
The replacement of the halogen substituent at the 6-position for a hydrophobic methyl group and the introduction of a bromine atom at the 8-position also alter the orientation of the allylmorpholine molecule within the bilayer, and 8-bromo-6-methyl-derivatives acquire the ability to increase φd, in contrast to their 6-bromo-analogs (Figure 14a). It is noteworthy that in this case the introduction of cyclohexane instead of isobutyl in the position does not affect the Δφd-value despite the increase in logD (by about 2).
The type of halogen substituent (bromine, fluorine, and chlorine at the 6-position) does not significantly affect the impact of these compounds on the change in φd (Figure 14b). The presence of an electron-withdrawing group at the 6-position of chromonylallylmorpholines is a key factor determining the molecule’s ability to reduce φd. The unsubstituted derivative exhibits virtually no dipole-modifying activity compared to the halogenated analogs or the nitro-substituted compound (Figure 14b).
Acetylcholinesterase and NMDA receptors are membrane-associated proteins, and changes to the lipid matrix caused by chromonylallylmorpholines can influence their conformational transitions and functionality. The reduction in φd triggered by allylmorpholines leads to an increase in the conductance of gramicidin A channels [244].

3.9. 1,3-Thiazine, 1,2,3,4-Dithiadiazole, and Thiohydrazide Derivatives

Over the last decade, thiazines, thiadiazoles, and thiohydrazides have gained attention for their sedative, antimicrobial, antiviral, antifungal, and antitumor properties. Notably, phenothiazines like methylene blue and azure dyes show antimicrobial, neuroprotective, and anticancer effects by intercalating with DNA, inhibiting key enzymes, and modulating cellular redox states. They are also used in photodynamic therapy to generate reactive oxygen species targeting pathogens or tumors [245,246]. Similarly, 1,2,3-dithiazoles exhibit antifungal, antibacterial, antiviral, and anticancer activity through ring-opening to form disulfides that disrupt enzyme activity or induce apoptosis. They inhibit melanin synthesis, act as herbicidal agents via gibberellin oxidase inhibition, and show antifibrotic potential [247]. Thiohydrazides, precursors to thiadiazoles, demonstrate anti-inflammatory, antiparasitic, and antitubercular effects by inhibiting enzymes like InhA and EthR in mycobacteria [248]. Their 1,3,4-thiadiazole derivatives halt cancer cell growth and offer analgesic and anticonvulsant benefits. Additionally, thiadiazoles are being studied for Alzheimer’s disease, diabetes, and inflammation [245]. Emerging research highlights 1,2,3,4-dithiadiazoles as promising inhibitors of store-operated calcium channels [249,250]. Future clinical success relies on resolving issues such as their interaction with membrane lipids.
Figure 15 presents a summary of literature findings regarding the dipole-modifying capacity of a series of thiazines, thiadiazoles, and thiohydrazides.
Based on the data obtained, it can be concluded that among the derivatives of thiohydrazides, containing not only nitrogen and sulfur atoms, but also fluorine, has the greatest ability to reduce the dipole potential of the membrane and has good prospects for use as a dipole-modifying agent. A decrease in the φd with N’-(3,5-difluorophenyl)-benzenecarbothiohydrazide adsorption facilitated the immersion of positively charged syringomycin E into the lipid bilayer and increases the pore-forming ability of the lipopeptide [251].
Literature indicates potential uses for derivatives of 1,2,3,4-dithiadiazole as novel calcium modulators, specifically inhibiting store-operated calcium entry [249,250,252], and the membrane-mediated component of such type of activity should be evaluated.

4. Summary

We categorized the compounds mentioned in this review into seven categories based on their dipole-modifying efficacy: agents that significantly increase φd (marked in burgundy); demonstrate moderate and slight enlargement in φd (marked in red and pink, respectively); do not practically affect φd (marked in black); slightly decrease φd (marked in cyan); have moderate dipole-diminishing efficiency (marked in blue); and significantly decrease φd (marked in dark blue) (Figure 16).
There are several compounds that are able to dramatically decrease membrane dipole potential (more than 100 mV): butein, phloretin, luteolin, myricetin, quercetin, biochanin A, Rose Bengal, capsaicin, dihydrocapsaicin, (E)-4-[1-(6-bromo-4-oxo-4H-chromen-3-yl)-4-methylpent-1-en-3-yl] morpholin-4-ium chloride, (E)-4-[1-(6-nitro-4-oxo-4H-chromen-3-yl)-4-methylpent-1-en-3-yl]morpholin-4-ium chloride, (E)-4-[1-(6-chloro-4-oxo-4H-chromen-3-yl)-4-methylpent-1-en-3-yl]morpholin-4-ium chloride, (E)-4-[1-(6-chloro-4-oxo-4H-chromen-3-yl)-pent-1-en-3-yl]morpholin-4-ium chloride, N’-(3,5-difluorophenyl)-benzenecarbothiohydrazide. Thus, chalcones, flavones, flavonols, isoflavones, halogenated xanthenes, benzylamines, and 6-halogen-substituted chromonylallylmorpholines are effective pharmacophores to reduce the dipole component of the membrane dipole potential. The decrease in the membrane dipole potential for these types of molecules is attributed to the incorporation of polar modifier molecules into the lipid bilayer. Structural modifications that affect not only the lipophilicity and polarity of compounds but also their orientation in the membrane should be taken into account. Molecular tools for significantly increasing the dipole potential are much more modest: this is only one stylyl dye, RH421.
The compiled repository of data on the effects of a wide range of low-molecular-weight natural and synthetic compounds on the physical properties of membranes of various compositions provides a valuable resource for gaining fundamental insights into lipid-mediated mechanisms of regulation of ion transport systems. It also enables the prediction of membrane activity of structurally related compounds and supports the development of combined antimicrobial agents comprising a pore-forming antibiotic and a small molecule potentiator.
However, it is important to note that the incorporation of small molecules into the bilayer leads not only to changes in its electrical properties but also to alterations in lipid packing density. The influence of small molecules on lipid melting thermograms has been studied via differential scanning microcalorimetry of lipid vesicles [93,94,151,244,251,253,254,255]. Figure 17 highlights key molecular properties (μ and logD values) and parameters of dipalmitoylphosphocholine melting endotherms (changes in the main phase transition temperature (ΔTm), in the half-width of the main peak (ΔT1/2), in the enthalpy of the main phase transition (∆∆Hcal), and the absence/presence of an additional shoulder on the main peak) when exposed to small molecules that significantly decrease membrane dipole potential (Δφd ≤ −100 mV). According to Jain and Wu [256], a certain pattern of alterations in the lipid melting thermogram can indicate the molecule’s membrane localization. In particular, a significant decrease in the Tm, an increase in the T1/2, and a constant ∆Hcal indicate localization of the guest molecule in the region of the C1–C9 atoms of the hydrocarbon chains of membrane-forming lipids (type A). If the ∆Hcal also decreases and an additional shoulder appears on the main peak, the molecule is thought to be located in the glycerol region (type B). If the introduction of a modifier molecule is accompanied only by a decrease in the ∆Hcal, then localization near the phosphocholine residue is assumed (type E or D, depending on the presence of a shoulder on the main peak). Small molecules that cause a dramatic decrease in melting temperature without significant changes in the T1/2 and the ∆Hcal are believed to be located in the C9–C16 region of the acyl chains of membrane lipids. The right column in Figure 17 shows the most probable localization of modifier molecules in the lipid bilayer according to the classification of Jain and Wu [256]. Only in the presence of Rose Bengal do the parameters of dipalmitoylphosphocholine melting thermograms remain almost unchanged (Figure 17), which does not allow us to make assumptions about its significant immersion into the lipid bilayer. However, molecular dynamics simulations revealed deeper penetration of the dye into the membrane [257]. Thus, the most effective dipole modifiers are characterized by preferential localization at the membrane–water interface or in the region between the hydrophilic and hydrophobic parts of the lipid bilayer. Moreover, Figure 17 shows a possible relationship between the dipole-modifying and disordering abilities of butein, phloretin, quercetin, biochanin A, capsaicin, dihydrocapsaicin, (E)-4-[1-(6-nitro-4-oxo-4H-chromen-3-yl)-4-methylpent-1-en-3-yl]mor-pholin-4-ium chloride, (E)-4-[1-(6-chloro-4-oxo-4H-chromen-3-yl)-4-methylpent-1-en-3-yl]morpholin-4-ium chloride, and (E)-4-[1-(6-chloro-4-oxo-4H-chromen-3-yl)-pent-1-en-3-yl] morpho-lin-4-ium chloride, as indicated by the noticeable alteration in Tm and T1/2.

5. Outlooks

Natural compounds from plants used in traditional medicine represent an important source for the search for membrane modifiers. Salvianolic acids, phytoconstituents from Salvia miltiorrhiza Bunge, having potential against coronary heart disease [258], might decrease φd, similar to rosmarinic acid. Among chalcone derivatives, boesenbergin A and 2′,4′-dihydroxy-6′-methoxy-3′,5′-dimethylchalcone, isolated from Boesenbergia rotunda and the buds of Cleistocalyx operculatus respectively [259,260], attract great attention. The high dipole-modifying activity of isoflavone tectorigenin, a main compound in Belamcanda chinensis, having strong analgesic and anti-inflammatory activities [261], flavone tectochrysin from Pinus krempfii Lecomte demonstrating acetylcholinesterase inhibitory activity [262], and analogs of curcumin, demethoxycurcumin, and bisdemethoxycurcumin, purified from Curcuma longa, which are dual inhibitors of protein tyrosine phosphatase 1B and α-glucosidase [263], may be proposed. Two flavonols, quercetin-3-O-methyl ether and kaempferol, for example, found in Camellia chrysantha [264] and various flavones, callistine A, eucalyptin, and 8-demethyleucalyptin, isolated from Callistemon citrinus [265], and flavones isolated from Isodon ternifolius [266], are also of great interest as membrane dipole modifiers. The dipole-modifying activity of luteolin tetramethyl ether, a chemical constituent of Desmodium gangeticum [267], and flavonols of Orthosiphon stamineus Benth., 5,7,3′,4′-tetramethylquercetin, 3′-hydroxy-3,5,7,4′-tetramethoxyflavone, and 3,5-dihydroxy-7,3′,4′-trimethoxyflavone [268], and isoflavanones from Desmodium heterophyllum (3R)–2′,4′,5,7-tetrahydroxy-6-methylisoflavanone and dalbergioidin [269], should be appropriately addressed. Paris saponin II from Paris polyphylla var. chinensis exhibiting cytotoxic effects against the MCF-7 human cancer cell line [270], and oleanolic triterpene saponins from Panax bipinnatifidus [271], ardinsuloside from Ardisia insularis [272], and saponin androseptoside A from Polyscias guilfoylei [273] might decrease φd similar to other glycosides of saponins. It was established that the alleviating atherosclerosis effect of kaempferol, widely distributed in a variety of Chinese herbal medicine, is related to inhibiting the Piezo1 channels and Ca++ influx by the flavonol [274]. Considering its high structural similarity with quercetin, myricetin and fisetin, which significantly reduce φd, one can assume the significance of its dipole-modifying properties in the regulation of ion transport through biomembranes.
Literature data indicate that many novel dipole-modifying agents are expected to be discovered, with several compounds already shown to alter φd significantly. Thus, 3-phenylindole, an antimicrobial, greatly enhances K+-nonactin-induced membrane conductance, which might indicate a decrease in φd [275]. Carbonylcyanide phenylhydrazone in charged and uncharged forms alters boundary potential and φd, inhibiting mitochondrial oxygen consumption and transport [276]. The calcium channel blocker verapamil changes φd, affecting membrane translocation and ion partitioning [143]. Trehalose decreases φd, while sucrose increases it, potentially by altering water molecules absorbed onto the lipid bilayer [277]. Arbutin diminishes φd as trehalose and phloretin but is believed to have an alternative mechanism of action [144]. N(alpha)-benzoyl-L-argininate ethyl ester chloride reduces φd more effectively than arginine because of its hydrophobic groups enhancing membrane insertion [278]. Procyanidins show biological activity linked to φd reduction, relevant for disease prevention and treatment [141]. Promising pharmacophores contained in essential oils ((E)-tagetone, (Z)-ocimenone, and thymol) and gallic acid may aid the discovery of new dipole-modifying agents [279,280].
A very important question is the possible relationship between changes in the elastic and electrical properties of the membrane [110,281,282]. The investigation into how small molecules can alter the elastic properties of membranes represents a distinct area of research that warrants further exploration. This line of inquiry could facilitate the identification of membrane modifiers useful for examining the regulation of mechanosensitive ion channels.
These findings suggest ongoing identification and characterization of new compounds with significant effects on φd, with potential applications in medicine and biology.

6. Conclusions

Understanding the membrane role in transport processes—including the function of ion channels, pumps, carriers, and membrane–drug interactions—requires a thorough description of the electrostatic properties of the lipid bilayer. One of the key components of the membrane electrostatic landscape is the dipole potential, an internal component of electrical potential originated by the specific orientation of dipoles of phospholipid headgroups and membrane-associated water molecules. This often-overlooked potential resides within the hydrophobic core of the bilayer and plays a fundamental role in modulating membrane function by affecting protein conformation, membrane ion permeability, and, cell signaling and cycle. The measured value of the dipole potential is highly method dependent. However, from a practical perspective, the absolute magnitude of the potential is less important than its alteration in response to a given process or perturbation.
Membrane dipole potential modifiers, such as polyphenols, alkaloids, saponins, certain hormones, synthetic dyes, and a number of drugs, including anesthetics and phosphodiesterase type 5 inhibitors, are amphiphilic molecules that alter the dipole potential by disrupting the lipid packing or orientation of interfacial water. These compounds serve as valuable experimental tools for probing the role of dipole potential in ion channel kinetics and protein function. Among them, certain biomolecules are of particular interest due to their low toxicity. Our understanding of such modifiers and their mechanisms of action continues to grow, underscoring the need for periodic review and systematic documentation of these molecular tools for potential biotechnological and pharmacological applications. Moreover, a detailed understanding of structure–activity relationships, particularly how specific chemical moieties influence the dipole potential, enables a more targeted approach to discovering and designing new modifiers.

Author Contributions

Conceptualization, S.S.E. and O.S.O.; formal analysis, S.S.E. and O.S.O.; investigation, S.S.E.; resources, O.S.O.; data curation, O.S.O.; writing—original draft preparation, S.S.E.; writing—review and editing, Q.M.P., H.T.T.T., L.Q.P. and O.S.O.; supervision, Q.M.P., L.Q.P. and O.S.O.; project administration, O.S.O.; funding acquisition, O.S.O. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Russian Science Foundation # 25-14-00162.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Conflicts of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.

References

  1. Honig, B.H.; Hubbell, W.L.; Flewelling, R.F. Electrostatic interactions in membranes and proteins. Annu. Rev. Biophys. Biophys. Chem. 1986, 15, 163–193. [Google Scholar] [CrossRef] [PubMed]
  2. Hille, B. Ion Channels of Excitable Membranes, 3rd ed.; Sinauer: Sunderland, MA, USA, 2001; p. 814. [Google Scholar]
  3. Fraser, J.A.; Huang, C.L. Quantitative techniques for steady-state calculation and dynamic integrated modelling of membrane potential and intracellular ion concentrations. Prog. Biophys. Mol. Biol. 2007, 94, 336–372. [Google Scholar] [CrossRef] [PubMed]
  4. Poignard, C.; Silve, A.; Campion, F.; Mir, L.M.; Saut, O.; Schwartz, L. Ion fluxes, transmembrane potential, and osmotic stabilization: A new dynamic electrophysiological model for eukaryotic cells. Eur. Biophys. J. 2011, 40, 235–246. [Google Scholar] [CrossRef] [PubMed]
  5. Kuge, O.; Nishijima, M. Biosynthetic regulation and intracellular transport of phosphatidylserine in mammalian cells. J. Biochem. 2003, 133, 397–403. [Google Scholar] [CrossRef]
  6. Leventis, P.A.; Grinstein, S. The distribution and function of phosphatidylserine in cellular membranes. Annu. Rev. Biophys. 2010, 39, 407–427. [Google Scholar] [CrossRef]
  7. Glade, M.J.; Smith, K. Phosphatidylserine and the human brain. Nutrition 2015, 31, 781–786. [Google Scholar] [CrossRef]
  8. Oliveira, D.L.; Nimrichter, L.; Miranda, K.; Frases, S.; Faull, K.F.; Casadevall, A.; Rodrigues, M.L. Cryptococcus neoformans cryoultramicrotomy and vesicle fractionation reveals an intimate association between membrane lipids and glucuronoxylomannan. Fungal Genet. Biol. 2009, 46, 956–963. [Google Scholar] [CrossRef]
  9. Parsons, J.B.; Rock, C.O. Bacterial lipids: Metabolism and membrane homeostasis. Prog. Lipid. Res. 2013, 52, 249–276. [Google Scholar] [CrossRef]
  10. Sohlenkamp, C.; Geiger, O. Bacterial membrane lipids: Diversity in structures and pathways. FEMS Microbiol. Rev. 2016, 40, 133–159. [Google Scholar] [CrossRef]
  11. Mitchison-Field, L.M.; Belin, B.J. Bacterial lipid biophysics and membrane organization. Curr. Opin. Microbiol. 2023, 74, 102315. [Google Scholar] [CrossRef]
  12. Smit, J.M.; Moesker, B.; Rodenhuis-Zybert, I.; Wilschut, J. Flavivirus cell entry and membrane fusion. Viruses 2011, 3, 160–171. [Google Scholar] [CrossRef]
  13. Mårtensson, C.U.; Doan, K.N.; Becker, T. Effects of lipids on mitochondrial functions. Biochim. Biophys. Acta. Mol. Cell Biol. Lipids. 2017, 1862, 102–113. [Google Scholar] [CrossRef] [PubMed]
  14. Franklin, J.C.; Cafiso, D.S. Internal electrostatic potentials in bilayers: Measuring and controlling dipole potentials in lipid vesicles. Biophys. J. 1993, 65, 289–299. [Google Scholar] [CrossRef] [PubMed]
  15. Wang, P.; Zhou, D.; Kinraide, T.B.; Luo, X.; Li, L.; Li, D.; Zhang, H. Cell membrane surface potential (psi0) plays a dominant role in the phytotoxicity of copper and arsenate. Plant Physiol. 2008, 148, 2134–2143. [Google Scholar] [CrossRef]
  16. Gouy, G.M. Sur la constitution de la charge electrique a la surface d’un electrolyte. Compt. Rend. 1910, 149, 654. [Google Scholar] [CrossRef]
  17. Stern, O. The theory of the electrolytic double-layer. Z. Elektrochem. Angew. Phys. Chem. 1924, 30, 508–516. [Google Scholar]
  18. Kinraide, T.B.; Yermiyahu, U.; Rytwo, G. Computation of surface electrical potentials of plant cell membranes. Correspondence To published zeta potentials from diverse plant sources. Plant Physiol. 1998, 118, 505–512. [Google Scholar] [CrossRef] [PubMed]
  19. Delgado, A.V.; González-Caballero, F.; Hunter, R.J.; Koopal, L.K.; Lyklema, J. International union of pure and applied chemistry, physical and biophysical chemistry division IUPAC technical report. Measurement and interpretation of electrokinetic phenomena. J. Colloid Interface Sci. 2007, 309, 194–224. [Google Scholar] [CrossRef]
  20. Mohammadi-Jam, S.; Waters, K.E.; Greenwood, R.W. A review of zeta potential measurements using electroacoustics. Adv. Colloid Interface Sci. 2022, 309, 102778. [Google Scholar] [CrossRef]
  21. Kaszuba, M.; Corbett, J.; Watson, F.M.; Jones, A. High-concentration zeta potential measurements using light-scattering techniques. Philos. Trans A Math. Phys. Eng. Sci. 2010, 368, 4439–4451. [Google Scholar] [CrossRef]
  22. Ermakov, Y.A. Electric fields at the lipid membrane interface. Membranes 2023, 13, 883. [Google Scholar] [CrossRef]
  23. Flewelling, R.F.; Hubbell, W.L. Hydrophobic ion interactions with membranes. Thermodynamic analysis of tetraphenylphosphonium binding to vesicles. Biophys. J. 1986, 49, 531–540. [Google Scholar] [CrossRef]
  24. Flewelling, R.F.; Hubbell, W.L. The membrane dipole potential in a total membrane potential model. Applications to hydrophobic ion interactions with membranes. Biophys. J. 1986, 49, 541–552. [Google Scholar] [CrossRef]
  25. Cseh, R.; Benz, R. The adsorption of phloretin to lipid monolayers and bilayers cannot be explained by langmuir adsorption isotherms alone. Biophys. J. 1998, 74, 1399–1408. [Google Scholar] [CrossRef][Green Version]
  26. Peterson, U.; Mannock, D.A.; Lewis, R.N.; Pohl, P.; McElhaney, R.N.; Pohl, E.E. Origin of membrane dipole potential: Contribution of the phospholipid fatty acid chains. Chem. Phys. Lipids. 2002, 117, 19–27. [Google Scholar] [CrossRef] [PubMed]
  27. Brockman, H.L.; Momsen, M.M.; Brown, R.E.; He, L.; Chun, J.; Byun, H.S.; Bittman, R. The 4,5-double bond of ceramide regulates its dipole potential, elastic properties, and packing behavior. Biophys. J. 2004, 87, 1722–1731. [Google Scholar] [CrossRef] [PubMed]
  28. Gawrisch, K.; Ruston, D.; Zimmerberg, J.; Parsegian, V.A.; Rand, R.P.; Fuller, N. Membrane dipole potentials, hydration forces, and the ordering of water at membrane surfaces. Biophys. J. 1992, 61, 1213–1223. [Google Scholar] [CrossRef] [PubMed]
  29. Liberman, E.A.; Topaly, V.P. Permeability of bimolecular phospholipid membranes for fat-soluble ions. Biofizika 1969, 14, 452–461. [Google Scholar]
  30. Hladky, S.B.; Haydon, D.A. Ion transfer across lipid membranes in the presence of gramicidin A. I. Studies of the unit conductance channel. Biochim. Biophys. Acta 1972, 274, 294–312. [Google Scholar] [CrossRef]
  31. Ketterer, B.; Neumcke, B.; Läuger, P. Transport mechanism of hydrophobic ions through lipid bilayer membranes. J. Membr. Biol. 1971, 5, 225–245. [Google Scholar] [CrossRef]
  32. Benz, R.; Cros, D. Influence of sterols on ion transport through lipid bilayer membranes. Biochim. Biophys. Acta 1978, 506, 265–280. [Google Scholar] [CrossRef]
  33. Clarke, R.J. Effect of lipid structure on the dipole potential of phosphatidylcholine bilayers. Biochim. Biophys. Acta 1997, 1327, 269–278. [Google Scholar] [CrossRef]
  34. Clarke, R.J. Effect of Cholesterol on the Dipole Potential of Lipid Membranes. Adv. Exp. Med. Biol. 2019, 1115, 135–154. [Google Scholar] [CrossRef]
  35. Shen, H.; Zhao, K.; Wu, Z. Effects of Ether Linkage on Membrane Dipole Potential and Cholesterol Flip-Flop Motion in Lipid Bilayer Membranes. J. Phys. Chem. B 2019, 123, 7818–7828. [Google Scholar] [CrossRef]
  36. Starke-Peterkovic, T.; Clarke, R.J. Effect of headgroup on the dipole potential of phospholipid vesicles. Eur. Biophys. J. 2009, 39, 103–110. [Google Scholar] [CrossRef]
  37. Shinoda, K.; Shinoda, W.; Baba, T.; Mikami, M. Comparative molecular dynamics study of ether- and ester-linked phospholipid bilayers. J. Chem. Phys. 2004, 121, 9648–9654. [Google Scholar] [CrossRef] [PubMed]
  38. Brockman, H. Dipole potential of lipid membranes. Chem. Phys. Lipids 1994, 73, 57–79. [Google Scholar] [CrossRef]
  39. Cardoso, R.M.S.; Lairion, F.; Disalvo, E.A.; Loura, L.M.S.; Moreno, M.J. Dipole Potential of Monolayers with Biologically Relevant Lipid Compositions. Molecules 2024, 29, 5843. [Google Scholar] [CrossRef] [PubMed]
  40. Clarke, R.J. The dipole potential of phospholipid membranes and methods for its detection. Adv. Colloid Interface Sci. 2001, 89–90, 263–281. [Google Scholar] [CrossRef] [PubMed]
  41. Sarkar, P.; Chattopadhyay, A. Membrane Dipole Potential: An Emerging Approach to Explore Membrane Organization and Function. J. Phys. Chem. B 2022, 126, 4415–4430. [Google Scholar] [CrossRef]
  42. Montana, V.; Farkas, D.L.; Loew, L.M. Dual-wavelength ratiometric fluorescence measurements of membrane potential. Biochem. 1989, 28, 4536–4539. [Google Scholar] [CrossRef]
  43. Demchenko, A.P.; Yesylevskyy, S.O. Nanoscopic description of biomembrane electrostatics: Results of molecular dynamics simulations and fluorescence probing. Chem. Phys. Lipids 2009, 160, 63–84. [Google Scholar] [CrossRef]
  44. Klymchenko, A.S.; Duportail, G.; Mély, Y.; Demchenko, A.P. Ultrasensitive two-color fluorescence probes for dipole potential in phospholipid membranes. Proc. Natl. Acad. Sci. USA 2003, 100, 11219–11224. [Google Scholar] [CrossRef]
  45. Shynkar, V.V.; Klymchenko, A.S.; Duportail, G.; Demchenko, A.P.; Mély, Y. Two-color fluorescent probes for imaging the dipole potential of cell plasma membranes. Biochim. Biophys. Acta 2005, 1712, 128–136. [Google Scholar] [CrossRef] [PubMed]
  46. Robinson, D.; Besley, N.A.; O’Shea, P.; Hirst, J.D. Di-8-ANEPPS emission spectra in phospholipid/cholesterol membranes: A theoretical study. J. Phys. Chem. B 2011, 115, 4160–4167. [Google Scholar] [CrossRef]
  47. Zhang, J.; Davidson, R.M.; Wei, M.D.; Loew, L.M. Membrane electric properties by combined patch clamp and fluorescence ratio imaging in single neurons. Biophys. J. 1998, 74, 48–53. [Google Scholar] [CrossRef] [PubMed]
  48. Jewell, S.A.; Petrov, P.G.; Winlove, C.P. The effect of oxidative stress on the membrane dipole potential of human red blood cells. Biochim. Biophys. Acta 2013, 1828, 1250–1258. [Google Scholar] [CrossRef] [PubMed]
  49. Singh, P.; Haldar, S.; Chattopadhyay, A. Differential effect of sterols on dipole potential in hippocampal membranes: Implications for receptor function. Biochim. Biophys. Acta 2013, 1828, 917–923. [Google Scholar] [CrossRef]
  50. Sarkar, P.; Rao, B.D.; Chattopadhyay, A. Cell cycle dependent modulation of membrane dipole potential and neurotransmitter receptor activity: Role of membrane cholesterol. ACS Chem. Neurosci. 2020, 11, 2890–2899. [Google Scholar] [CrossRef]
  51. Andersen, O.S.; Finkelstein, A.; Katz, I.; Cass, A. Effect of phloretin on the permeability of thin lipid membranes. J. Gen. Physiol. 1976, 67, 749–771. [Google Scholar] [CrossRef]
  52. Sokolov, V.S.; Cherny, V.V.; Markin, V.S. Measurement of potential jumps during the adsorption of phloretin and phloricin on the surface of lipid membranes using the intramembrane field compensation method. Biophysics 1984, 29, 424–429. [Google Scholar]
  53. Simonova, M.V.; Cherny, V.V.; Donat, E.; Sokolov, V.S.; Markin, V.S. Boundary potentials on a bilayer membrane in the presence of rimantadine. Analysis of three measurement methods. Biochem. Moscow Suppl. Ser. A 1986, 3, 846–857. [Google Scholar]
  54. Shen, H.; Wu, Z.; Deng, M.; Wen, S.; Gao, C.; Li, S.; Wu, X. Molecular Dynamics Simulations of Ether- and Ester-Linked Phospholipid Bilayers: A Comparative Study of Water Models. J Phys Chem B 2018, 122, 9399–9408. [Google Scholar] [CrossRef]
  55. Falkovich, S.G.; Martinez-Seara, H.; Nesterenko, A.M.; Vattulainen, I.; Gurtovenko, A.A. What Can We Learn about Cholesterol’s Transmembrane Distribution Based on Cholesterol-Induced Changes in Membrane Dipole Potential? J. Phys. Chem. Lett. 2016, 7, 4585–4590. [Google Scholar] [CrossRef]
  56. Högberg, C.J.; Lyubartsev, A.P. Effect of local anesthetic lidocaine on electrostatic properties of a lipid bilayer. Biophys. J. 2008, 94, 525–531. [Google Scholar] [CrossRef]
  57. Shen, H.; Wu, Z.; Lu, C. Extension of the CAVS model to the simulation of helical peptides in a membrane environment. Phys. Chem. Chem. Phys. 2021, 23, 12850–12863. [Google Scholar] [CrossRef] [PubMed]
  58. Shen, H.; Wu, Z.; Zou, X. Interfacial Water Structure at Zwitterionic Membrane/Water Interface: The Importance of Interactions between Water and Lipid Carbonyl Groups. ACS Omega 2020, 5, 18080–18090. [Google Scholar] [CrossRef] [PubMed]
  59. Zhan, H.; Lazaridis, T. Influence of the membrane dipole potential on peptide binding to lipid bilayers. Biophys. Chem. 2012, 161, 1–7. [Google Scholar] [CrossRef][Green Version]
  60. Rasouli, A.; Jamali, Y.; Tajkhorshid, E.; Bavi, O.; Pishkenari, H.N. Mechanical properties of ester- and ether-DPhPC bilayers: A molecular dynamics study. J. Mech. Behav. Biomed. Mater. 2021, 117, 104386. [Google Scholar] [CrossRef]
  61. Baumgart, A.; Le, D.T.; Cranfield, C.G.; Bridge, S.; Zerlotti, R.; Palchetti, I.; Tadini-Buoninsegni, F.; Clarke, R.J. Membrane Binding of Hydrophobic Ions: Application of New Kinetic Techniques. Langmuir 2025, 41, 8081–8091. [Google Scholar] [CrossRef] [PubMed]
  62. Finkelstein, A.; Andersen, O.S. The gramicidin A channel: A review of its permeability characteristics with special reference to the single-file aspect of transport. J. Membr. Biol. 1981, 59, 155–171. [Google Scholar] [CrossRef] [PubMed]
  63. Hidaka, Y.; Asami, K. Measurement of dipole potential in bilayer lipid membranes by dielectric spectroscopy. J. Membr. Biol. 2014, 247, 721–727. [Google Scholar] [CrossRef]
  64. Wang, L.; Bose, P.S.; Sigworth, F.J. Using cryo-EM to measure the dipole potential of a lipid mem brane. Proc. Natl. Acad. Sci. USA 2006, 103, 18528–18533. [Google Scholar] [CrossRef]
  65. Heberle, F.A.; Welsch, D.; Scott, H.L.; Waxham, M.N. Optimization of cryo-electron microscopy for quantitative analysis of lipid bilayers. Biophys. Rep. 2022, 3, 100090. [Google Scholar] [CrossRef]
  66. Yang, Y.; Mayer, K.M.; Wickremasinghe, N.S.; Hafner, J.H. Probing the lipid membrane dipole potential by atomic force microscopy. Biophys. J. 2008, 95, 5193–5199. [Google Scholar] [CrossRef]
  67. Szabo, M.; Cs Szabo, B.; Kurtan, K.; Varga, Z.; Panyi, G.; Nagy, P.; Zakany, F.; Kovacs, T. Look Beyond Plasma Membrane Biophysics: Revealing Considerable Variability of the Dipole Potential Between Plasma and Organelle Membranes of Living Cells. Int. J. Mol. Sci. 2025, 26, 889. [Google Scholar] [CrossRef] [PubMed]
  68. Haldar, S.; Kanaparthi, R.K.; Samanta, A.; Chattopadhyay, A. Differential effect of cholesterol and its biosynthetic precursors on membrane dipole potential. Biophys. J. 2012, 102, 1561–1569. [Google Scholar] [CrossRef] [PubMed]
  69. Strichartz, G.R.; Oxford, G.S.; Ramon, F. Effects of the dipolar form of phloretin on potassium conductance in squid giant axons. Biophys. J. 1980, 31, 229–246. [Google Scholar] [CrossRef]
  70. Vandenberg, J.I.; Perry, M.D.; Perrin, M.J.; Mann, S.A.; Ke, Y.; Hill, A.P. hERG K+ Channels: Structure, Function, and Clinical Significance. Physiol. Rev. 2012, 92, 1393–1478. [Google Scholar] [CrossRef]
  71. Pearlstein, R.A.; Dickson, C.J.; Hornak, V. Contributions of the membrane dipole potential to the function of voltage-gated cation channels and modulation by small molecule potentiators. Biochim. Biophys. Acta Biomembr. 2017, 1859, 177–194. [Google Scholar] [CrossRef]
  72. Asandei, A.; Mereuta, L.; Luchian, T. Influence of membrane potentials upon reversible protonation of acidic residues from the OmpF eyelet. Biophys. Chem. 2008, 135, 32–40. [Google Scholar] [CrossRef] [PubMed][Green Version]
  73. Summhammer, J.; Salari, V.; Bernroider, G. A quantum-mechanical description of ion motion within the confining potentials of voltage-gated ion channels. J. Integr. Neurosci. 2012, 11, 123–135. [Google Scholar] [CrossRef] [PubMed]
  74. Adhya, L.; Mapder, T.; Adhya, S. Role of terminal dipole charges in aggregation of α-helix pair in the voltage gated K(+) channel. Biochim. Biophys. Acta 2013, 1828, 2795. [Google Scholar] [CrossRef]
  75. Sobolevsky, A.I.; Yelshansky, M.V.; Wollmuth, L.P. State-dependent changes in the electrostatic potential in the pore of a GluR channel. Biophys. J. 2005, 88, 235–242. [Google Scholar] [CrossRef]
  76. Oh, S.; Rivkin, S.; Tang, Q.; Verselis, V.K.; Bargiello, T.A. Determinants of gating polarity of a connexin 32 hemichannel. Biophys. J. 2004, 87, 912–928. [Google Scholar] [CrossRef]
  77. Mehnert, T.; Lam, Y.H.; Judge, P.J.; Routh, A.; Fischer, D.; Watts, A.; Fischer, W.B. Towards a mechanism of function of the viral ion channel Vpu from HIV-1. J. Biomol. Struct. Dyn. 2007, 24, 589–596. [Google Scholar] [CrossRef]
  78. Knyazev, D.G.; Kuttner, R.; Bondar, A.N.; Zimmerman, M.; Siligan, C.; Pohl, P. Voltage Sensing in Bacterial Protein Translocation. Biomolecules 2020, 10, 78. [Google Scholar] [CrossRef]
  79. Qu, W.; Moorhouse, A.J.; Chandra, M.; Pierce, K.D.; Lewis, T.M.; Barry, P.H. A single P-loop glutamate point mutation to either lysine or arginine switches the cation-anion selectivity of the CNGA2 channel. J. Gen. Physiol. 2006, 127, 375–389. [Google Scholar] [CrossRef]
  80. Chakrabarti, N.; Roux, B.; Pomès, R. Structural determinants of proton blockage in aquaporins. J. Mol. Biol. 2004, 343, 493–510. [Google Scholar] [CrossRef]
  81. Rokitskaya, T.I.; Antonenko, Y.N.; Kotova, E.A. Effect of the dipole potential of a bilayer lipid membrane on gramicidin channel dissociation kinetics. Biophys. J. 1997, 73, 850–854. [Google Scholar] [CrossRef]
  82. Busath, D.D.; Thulin, C.D.; Hendershot, R.W.; Phillips, L.R.; Maughan, P.; Cole, C.D.; Bingham, N.C.; Morrison, S.; Baird, L.C.; Hendershot, R.J.; et al. Noncontact dipole effects on channel permeation. I. Experiments with (5F-indole)Trp13 gramicidin A channels. Biophys. J. 1998, 75, 2830–2844. [Google Scholar] [CrossRef]
  83. Ostroumova, O.S.; Malev, V.V.; Bessonov, A.N.; Takemoto, J.Y.; Schagina, L.V. Altering the activity of syringomycin E via the membrane dipole potential. Langmuir 2008, 24, 2987–2991. [Google Scholar] [CrossRef]
  84. Rokitskaya, T.I.; Kotova, E.A.; Antonenko, Y.N. Membrane dipole potential modulates proton conductance through gramicidin channel: Movement of negative ionic defects inside the channel. Biophys. J. 2002, 82, 865–873. [Google Scholar] [CrossRef]
  85. Schagina, L.V.; Gurnev, P.A.; Takemoto, J.Y.; Malev, V.V. Effective gating charge of ion channels induced by toxin syringomycin E in lipid bilayers. Bioelectrochemistry 2003, 60, 21–27. [Google Scholar] [CrossRef] [PubMed]
  86. Luchian, T.; Mereuta, L. Phlorizin- and 6-ketocholestanol-mediated antagonistic modulation of alamethicin activity in phospholipid planar membranes. Langmuir 2006, 22, 8452–8457. [Google Scholar] [CrossRef] [PubMed]
  87. Asandei, A.; Luchian, T. Ion selectivity, transport properties and dynamics of amphotericin B channels studied over a wide range of acidity changes. Colloids Surf. B Biointerfaces 2008, 67, 99–106. [Google Scholar] [CrossRef]
  88. Apetrei, A.; Mereuta, L.; Luchian, T. The RH 421 styryl dye induced, pore model-dependent modulation of antimicrobial peptides activity in reconstituted planar membranes. Biochim. Biophys. Acta 2009, 1790, 809–816. [Google Scholar] [CrossRef]
  89. Ostroumova, O.S.; Malev, V.V.; Ilin, M.G.; Schagina, L.V. Surfactin activity depends on the membrane dipole potential. Langmuir 2010, 26, 15092–15097. [Google Scholar] [CrossRef] [PubMed]
  90. Mereuta, L.; Asandei, A.; Luchian, T. Meet me on the other side: Trans-bilayer modulation of a model voltage-gated ion channel activity by membrane electrostatics asymmetry. PLoS ONE 2011, 6, e25276. [Google Scholar] [CrossRef][Green Version]
  91. Efimova, S.S.; Schagina, L.V.; Ostroumova, O.S. Channel-forming activity of cecropins in lipid bilayers: Effect of agents modifying the membrane dipole potential. Langmuir 2014, 30, 7884–7892. [Google Scholar] [CrossRef]
  92. Efimova, S.S.; Zakharova, A.A.; Schagina, L.V.; Ostroumova, O.S. Local Anesthetics Affect Gramicidin A Channels via Membrane Electrostatic Potentials. J. Membr. Biol. 2016, 249, 781–787. [Google Scholar] [CrossRef]
  93. Efimova, S.S.; Zakharova, A.A.; Medvedev, R.Y.; Ostroumova, O.S. Ion channels induced by antimicrobial agents in model lipid membranes are modulated by plant polyphenols through surrounding lipid media. J. Membr. Biol. 2018, 251, 551–562. [Google Scholar] [CrossRef] [PubMed]
  94. Efimova, S.S.; Zakharova, A.A.; Ismagilov, A.A.; Schagina, L.V.; Malev, V.V.; Bashkirov, P.V.; Ostroumova, O.S. Lipid-mediated regulation of pore-forming activity of syringomycin E by thyroid hormones and xanthene dyes. Biochim. Biophys. Acta Biomembr. 2018, 1860, 691–699. [Google Scholar] [CrossRef] [PubMed]
  95. Zakharova, A.A.; Efimova, S.S.; Ostroumova, O.S. Lipid Microenvironment Modulates the Pore-Forming Ability of Polymyxin B. Antibiotics 2022, 11, 1445. [Google Scholar] [CrossRef] [PubMed]
  96. Chernyshova, D.N.; Tyulin, A.A.; Ostroumova, O.S.; Efimova, S.S. Discovery of the Potentiator of the Pore-Forming Ability of Lantibiotic Nisin: Perspectives for Anticancer Therapy. Membranes 2022, 12, 1166. [Google Scholar] [CrossRef]
  97. Kovács, T.; Batta, G.; Hajdu, T.; Szabó, Á.; Váradi, T.; Zákány, F.; Csomós, I.; Szöllősi, J.; Nagy, P. The Dipole Potential Modifies the Clustering and Ligand Binding Affinity of ErbB Proteins and Their Signaling Efficiency. Sci. Rep. 2016, 6, 35850. [Google Scholar] [CrossRef]
  98. Starke-Peterkovic, T.; Turner, N.; Else, P.L.; Clarke, R.J. Electric field strength of membrane lipids from vertebrate species: Membrane lipid composition and Na+-K+-ATPase molecular activity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 288, R663–R670. [Google Scholar] [CrossRef]
  99. Mares, L.J.; Garcia, A.; Rasmussen, H.H.; Cornelius, F.; Mahmmoud, Y.A.; Berlin, J.R.; Lev, B.; Allen, T.W.; Clarke, R.J. Identification of electric-field-dependent steps in the Na(+), K(+)-pump cycle. Biophys. J. 2014, 107, 1352–1363. [Google Scholar] [CrossRef]
  100. Karlovská, J.; Uhríková, D.; Kucerka, N.; Teixeira, J.; Devínsky, F.; Lacko, I.; Balgavý, P. Influence of N-dodecyl-N,N-dimethylamine N-oxide on the activity of sarcoplasmic reticulum Ca(2+)-transporting ATPase reconstituted into diacylphosphatidylcholine vesicles: Efects of bilayer physical parameters. Biophys. Chem. 2006, 119, 69–77. [Google Scholar] [CrossRef]
  101. Tadini-Buoninsegni, F.; Moncelli, M.R.; Peruzzi, N.; Ninham, B.W.; Dei, L.; Nostro, P.L. Hofmeister effect of anions on calcium translocation by sarcoplasmic reticulum Ca(2+)-ATPase. Sci. Rep. 2015, 5, 14282. [Google Scholar] [CrossRef]
  102. Clarke, R.J. Dipole-Potential-Mediated Effects on Ion Pump Kinetics. Biophys. J. 2015, 109, 1513–1520. [Google Scholar] [CrossRef]
  103. Maggio, B. Modulation of phospholipase A2 by electrostatic fields and dipole potential of glycosphingolipids in monolayers. J. Lipid Res. 1999, 40, 930−939. [Google Scholar] [CrossRef]
  104. Xu, C.; Loew, L.M. Activation of phospholipase C increases intramembrane electric fields in N1E-115 neuroblastoma cells. Biophys. J. 2003, 84, 4144–4156. [Google Scholar] [CrossRef]
  105. Cladera, J.; O’Shea, P. Intramembrane molecular dipoles affect the membrane insertion and folding of a model amphiphilic peptide. Biophys. J. 1998, 74, 2434–2442. [Google Scholar] [CrossRef]
  106. Oishi, K.; Zheng, B.; White, J.F.; Vogler, W.R.; Kuo, J.F. Inhibition of Na,K-ATPase and sodium pump by anticancer ether lipids and protein kinase C inhibitors ET-18-OCH3 and BM 41.440. Biochem. Biophys. Res. Commun. 1988, 157, 1000–1006. [Google Scholar] [CrossRef] [PubMed]
  107. Jewell, S.A.; Titball, R.W.; Huyet, J.; Naylor, C.E.; Basak, A.K.; Gologan, P.; Winlove, C.P.; Petrov, P.G. Clostridium perfringensα-toxin interaction with red cells and model membranes. Soft. Matter. 2015, 11, 7748–7761. [Google Scholar] [CrossRef]
  108. Kovács, T.; Batta, G.; Zákány, F.; Szöllősi, J.; Nagy, P. The dipole potential correlates with lipid raft markers in the plasma membrane of living cells. J. Lipid Res. 2017, 58, 1681–1691. [Google Scholar] [CrossRef] [PubMed]
  109. Efimova, S.S.; Zakharova, A.A.; Schagina, L.V.; Ostroumova, O.S. Two types of syringomycin E channels in sphingomyelin-containing bilayers. Eur. Biophys. J. 2016, 45, 91–98. [Google Scholar] [CrossRef]
  110. Batta, G.; Hajdu, T.; Nagy, P. Characterization of the Effect of Sphingolipid Accumulation on Membrane Compactness, Dipole Potential, and Mobility of Membrane Components. Methods Mol. Biol. 2021, 2187, 283–301. [Google Scholar] [CrossRef] [PubMed]
  111. Davis, S.; Davis, B.M.; Richens, J.L.; Vere, K.A.; Petrov, P.G.; Winlove, C.P.; O’Shea, P. α-Tocopherols modify the membrane dipole potential leading to modulation of ligand binding by P-glycoprotein. J. Lipid Res. 2015, 56, 1543–1550. [Google Scholar] [CrossRef]
  112. Mai, T.L.; Nguyen, H.T.; Derreumaux, P.; Nguyen, P.H. Structure and elasticity of healthy and Alzheimer’s disease cell membranes revealed by molecular dynamics simulations. Proteins 2025, 93, 1349–1360. [Google Scholar] [CrossRef]
  113. Sarkar, P.; Chattopadhyay, A. Solubilization of the serotonin1A receptor monitored utilizing membrane dipole potential. Chem. Phys. Lipids 2017, 209, 54–60. [Google Scholar] [CrossRef] [PubMed]
  114. Cladera, J.; Martin, I.; Ruysschaert, J.M.; O’Shea, P. Characterization of the sequence of interactions of the fusion domain of the simian immunodeficiency virus with membranes. Role of the membrane dipole potential. J. Biol. Chem. 1999, 274, 29951–29959. [Google Scholar] [CrossRef] [PubMed]
  115. Buzón, V.; Cladera, J. Effect of cholesterol on the interaction of the HIV GP41 fusion peptide with model membranes. Importance of the membrane dipole potential. Biochemistry 2006, 45, 15768–15775. [Google Scholar] [CrossRef]
  116. Gomes, B.; Gonçalves, S.; Disalvo, A.; Hollmann, A.; Santos, N.C. Effect of 25-hydroxycholesterol in viral membrane fusion: Insights on HIV inhibition. Biochim. Biophys. Acta Biomembr. 2018, 1860, 1171–1178. [Google Scholar] [CrossRef]
  117. Asawakarn, T.; Cladera, J.; O’Shea, P. Effects of the membrane dipole potential on the interaction of saquinavir with phospholipid membranes and plasma membrane receptors of Caco-2 cells. J. Biol. Chem. 2001, 276, 38457–38463. [Google Scholar] [CrossRef] [PubMed]
  118. Matos, P.M.; Freitas, T.; Castanho, M.A.; Santos, N.C. The role of blood cell membrane lipids on the mode of action of HIV-1 fusion inhibitor sifuvirtide. Biochem. Biophys. Res. Commun. 2010, 403, 270–274. [Google Scholar] [CrossRef]
  119. Matos, P.M.; Castanho, M.A.; Santos, N.C. HIV-1 fusion inhibitor peptides enfuvirtide and T-1249 interact with erythrocyte and lymphocyte membranes. PLoS ONE 2010, 5, e9830. [Google Scholar] [CrossRef]
  120. Hollmann, A.; Matos, P.M.; Augusto, M.T.; Castanho, M.A.; Santos, N.C. Conjugation of cholesterol to HIV-1 fusion inhibitor C34 increases peptide-membrane interactions potentiating its action. PLoS ONE 2013, 8, e60302. [Google Scholar] [CrossRef]
  121. Guillén, J.; Kinnunen, P.K.; Villalaín, J. Membrane insertion of the three main membranotropic sequences from SARS-CoV S2 glycoprotein. Biochim. Biophys. Acta 2008, 1778, 2765–2774. [Google Scholar] [CrossRef]
  122. Shen, H.; Wu, Q.; Chen, L. Binding of SARS-CoV-2 fusion peptides to hybrid phospholipid bilayers: Exploring the influence of ether-linked phospholipids. Phys. Chem. Chem. Phys. 2025, 27, 16962–16971. [Google Scholar] [CrossRef]
  123. Alakoskela, J.M.; Söderlund, T.; Holopainen, J.M.; Kinnunen, P.K. Dipole potential and head-group spacing are determinants for the membrane partitioning of pregnanolone. Mol. Pharmacol. 2004, 66, 161–168. [Google Scholar] [CrossRef]
  124. Via, M.A.; Klug, J.; Wilke, N.; Mayorga, L.S.; Del Pópolo, M.G. The interfacial electrostatic potential modulates the insertion of cell-penetrating peptides into lipid bilayers. Phys. Chem. Chem. Phys. 2018, 20, 5180–5189. [Google Scholar] [CrossRef]
  125. Batta, G.; Kárpáti, L.; Henrique, G.F.; Tóth, G.; Tarapcsák, S.; Kovacs, T.; Zakany, F.; Mándity, I.M.; Nagy, P. Statin-boosted cellular uptake and endosomal escape of penetratin due to reduced membrane dipole potential. Br. J. Pharmacol. 2021, 178, 3667–3681. [Google Scholar] [CrossRef] [PubMed]
  126. Via, M.A.; Del Pópolo, M.G.; Wilke, N. Negative Dipole Potentials and Carboxylic Polar Head Groups Foster the Insertion of Cell-Penetrating Peptides into Lipid Monolayers. Langmuir 2018, 34, 3102–3111. [Google Scholar] [CrossRef]
  127. Cladera, J.; O’Shea, P.; Hadgraft, J.; Valenta, C. Influence of molecular dipoles on human skin permeability: Use of 6-ketocholestanol to enhance the transdermal delivery of bacitracin. J. Pharm. Sci. 2003, 92, 1018–1027. [Google Scholar] [CrossRef]
  128. Prince, A.; Sandhu, P.; Ror, P.; Dash, E.; Sharma, S.; Arakha, M.; Jha, S.; Akhter, Y.; Saleem, M. Lipid-II Independent Antimicrobial Mechanism of Nisin Depends On Its Crowding And Degree Of Oligomerization. Sci. Rep. 2017, 7, 41346. [Google Scholar] [CrossRef] [PubMed]
  129. Felício, M.R.; Silveira, G.G.O.S.; Oshiro, K.G.N.; Meneguetti, B.T.; Franco, O.L.; Santos, N.C.; Gonçalves, S. Polyalanine peptide variations may have different mechanisms of action against multidrug-resistant bacterial pathogens. J. Antimicrob. Chemother. 2021, 76, 1174–1186. [Google Scholar] [CrossRef]
  130. Silvestroni, L.; Fiorini, R.; Palleschi, S. Partition of the organochlorine insecticide lindane into the human sperm surface induces membrane depolarization and Ca2+ influx. Biochem. J. 1997, 321, 691–698. [Google Scholar] [CrossRef] [PubMed]
  131. Reyes, J.; Latorre, R. Effect of the anesthetics benzyl alcohol and chloroform on bilayers made from monolayers. Biophys. J. 1979, 28, 259–279. [Google Scholar] [CrossRef]
  132. Cafiso, D.S. Dipole potentials and spontaneous curvature: Membrane properties that could mediate anesthesia. Toxicol. Lett. 1998, 100–101, 431–439. [Google Scholar] [CrossRef] [PubMed]
  133. Davis, B.M.; Brenton, J.; Davis, S.; Shamsher, E.; Sisa, C.; Grgic, L.; Cordeiro, M.F. Assessing anesthetic activity through modulation of the membrane dipole potential. J. Lipid Res. 2017, 58, 1962–1976. [Google Scholar] [CrossRef]
  134. Jalili, S.; Saeedi, M. Study of procaine and tetracaine in the lipid bilayer using molecular dynamics simulation. Eur. Biophys. J. 2017, 46, 265–282. [Google Scholar] [CrossRef]
  135. Qin, Z.; Szabo, G.; Cafiso, D.S. Anesthetics reduce the magnitude of the membrane dipole potential. Measurements in lipid vesicles using voltage-sensitive spin probes. Biochemistry 1995, 34, 5536–5543. [Google Scholar] [CrossRef]
  136. Shrivastava, S.; Ror, P.; Chattopadhyay, A. Effect of Local Anesthetics on Dipole Potential of Different Phase Membranes: A Fluorescence Study. J. Membr. Biol. 2022, 255, 363–369. [Google Scholar] [CrossRef] [PubMed]
  137. Esteruelas, G.; Ortiz, A.; Prat, J.; Vega, E.; Muñoz-Juncosa, M.; López, M.L.G.; Ettcheto, M.; Camins, A.; Sánchez-López, E.; Pujol, M. Novel customized age-dependent corneal membranes and interactions with biodegradable nanoparticles loaded with dexibuprofen. Colloids Surf. B Biointerfaces 2023, 228, 113394. [Google Scholar] [CrossRef] [PubMed]
  138. Terreiro, J.F.P.R.; Marquês, J.T.; Antunes, I.; de Faria, C.F.; Santos, S.; Martins, F.; de Almeida, R.F.M. Membrane interaction studies of isoniazid derivatives active against drug-resistant tuberculosis. Eur. J. Pharm. Sci. 2025, 205, 106986. [Google Scholar] [CrossRef]
  139. Szomek, M.; Akkerman, V.; Lauritsen, L.; Walther, H.L.; Juhl, A.D.; Thaysen, K.; Egebjerg, J.M.; Covey, D.F.; Lehmann, M.; Wessig, P.; et al. Ergosterol promotes aggregation of natamycin in the yeast plasma membrane. Biochim. Biophys. Acta Biomembr. 2024, 1866, 184350. [Google Scholar] [CrossRef]
  140. Starosta, R.; Santos, T.C.; Dinis de Sousa, A.F.; Santos, M.S.; Corvo, M.L.; Tomaz, A.I.; de Almeida, R.F.M. Assessing the role of membrane lipids in the action of ruthenium(III) anticancer compounds. Front. Mol. Biosci. 2023, 9, 1059116. [Google Scholar] [CrossRef]
  141. Cyboran-Mikołajczyk, S.; Żyłka, R.; Jurkiewicz, P.; Pruchnik, H.; Oszmiański, J.; Hof, M.; Kleszczyńska, H. Interaction of procyanidin B3 with membrane lipids - Fluorescence, DSC and FTIR studies. Biochim. Biophys. Acta Biomembr. 2017, 1859, 1362–1371. [Google Scholar] [CrossRef]
  142. Borba, A.; Lairion, F.; Disalvo, A.; Fausto, R. Interaction of nicotinamide and picolinamide with phosphatidylcholine and phosphatidylethanolamine membranes: A combined approach using dipole potential measurements and quantum chemical calculations. Biochim. Biophys. Acta 2009, 1788, 2553–2562. [Google Scholar] [CrossRef][Green Version]
  143. Pohl, E.E.; Krylov, A.V.; Block, M.; Pohl, P. Changes of the membrane potential profile induced by verapamil and propranolol. Biochim. Biophys. Acta 1998, 1373, 170–178. [Google Scholar] [CrossRef]
  144. Lairion, F.; Disalvo, E.A. Effect of arbutin on the dipole potential and area per lipid of ester and ether phosphatidylcholine and phosphatidyl ethanolamine monolayers. Biochim. Biophys. Acta 2007, 1768, 450–456. [Google Scholar] [CrossRef][Green Version]
  145. Sethy, D.; Chakraborty, H. Micellar dipolar rearrangement is sensitive to hydrophobic chain length: Implication for structural switchover of piroxicam. Chem. Phys. Lipids 2016, 200, 120–125. [Google Scholar] [CrossRef]
  146. Mazurkiewicz, E.; Obłak, E.; Paściak, M.; Gamian, A.; Ciesielska, M.; Lamch, Ł.; Wilk, K.A. The structure-dependent effects of newly synthesised cationic gemini surfactants against yeast cells. Sci. Rep. 2025, 9, 604. [Google Scholar] [CrossRef]
  147. Matti, V.; Säily, J.; Ryhänen, S.J.; Holopainen, J.M.; Borocci, S.; Mancini, G.; Kinnunen, P.K. Characterization of mixed monolayers of phosphatidylcholine and a dicationic gemini surfactant SS-1 with a langmuir balance: Effects of DNA. Biophys. J. 2001, 89, 753. [Google Scholar] [CrossRef] [PubMed][Green Version]
  148. Conde-Torres, D.; Calvelo, M.; Rovira, C.; Piñeiro, Á.; Garcia-Fandino, R. Unlocking the specificity of antimicrobial peptide interactions for membrane-targeted therapies. Comput. Struct. Biotechnol. J. 2024, 25, 61–74. [Google Scholar] [CrossRef] [PubMed]
  149. Efimova, S.S.; Ostroumova, O.S. Effect of dipole modifiers on the magnitude of the dipole potential of sterol-containing bilayers. Langmuir 2012, 28, 9908–9914. [Google Scholar] [CrossRef]
  150. Pohl, P.; Rokitskaya, T.I.; Pohl, E.E.; Saparov, S.M. Permeation of phloretin across bilayer lipid membranes monitored by dipole potential and microelectrode measurements. Biochim. Biophys. Acta 1997, 1323, 163–172. [Google Scholar] [CrossRef]
  151. Efimova, S.S.; Zakharova, A.A.; Ostroumova, O.S. Alkaloids Modulate the Functioning of Ion Channels Produced by Antimicrobial Agents via an Influence on the Lipid Host. Front. Cell Dev. Biol. 2020, 8, 537. [Google Scholar] [CrossRef] [PubMed]
  152. Efimova, S.S.; Ostroumova, O.S. Is the Membrane Lipid Matrix a Key Target for Action of Pharmacologically Active Plant Saponins? Int. J. Mol. Sci. 2021, 22, 3167. [Google Scholar] [CrossRef]
  153. Martynyuk, V.A.; Efimova, S.S.; Malykhina, A.I.; Ostroumova, O.S. The effects of plant flavones on the membrane boundary potential and lipid packing stress. Colloids Surf. B Biointerfaces 2025, 245, 114269. [Google Scholar] [CrossRef]
  154. Lev, B.; Vorobyov, I.; Clarke, R.J.; Allen, T.W. The Membrane Dipole Potential and the Roles of Interfacial Water and Lipid Hydrocarbon Chains. J. Phys. Chem. B 2024, 128, 9482–9499. [Google Scholar] [CrossRef]
  155. Galassi, V.V.; Wilke, N. On the Coupling between Mechanical Properties and Electrostatics in Biological Membranes. Membranes 2021, 11, 478. [Google Scholar] [CrossRef] [PubMed]
  156. Warshaviak, D.T.; Muellner, M.J.; Chachisvilis, M. Effect of membrane tension on the electric field and dipole potential of lipid bilayer membrane. Biochim. Biophys. Acta 2011, 1808, 2608–2617. [Google Scholar] [CrossRef]
  157. Levental, K.R.; Lorent, J.H.; Lin, X.; Skinkle, A.D.; Surma, M.A.; Stockenbojer, E.A.; Gorfe, A.A.; Levental, I. Polyunsaturated lipids regulate membrane domain stability by tuning membrane order. Biophys. J. 2016, 110, 1800–1810. [Google Scholar] [CrossRef]
  158. Shahi, G.; Kumar, M.; Kumari, S.; Rudramurthy, S.M.; Chakrabarti, A.; Gaur, N.A.; Singh, A.; Prasad, R. A detailed lipidomic study of human pathogenic fungi Candida auris. FEMS Yeast Res. 2020, 20, foaa045. [Google Scholar] [CrossRef]
  159. Alara, O.R.; Abdurahman, N.H.; Ukaegbu, C.I. Extraction of phenolic compounds: A review. Curr. Res. Food Sci. 2021, 4, 200–214. [Google Scholar] [CrossRef] [PubMed]
  160. Tsao, R. Chemistry and biochemistry of dietary polyphenols. Nutrients 2010, 2, 1231–1246. [Google Scholar] [CrossRef] [PubMed]
  161. Chaachouay, N.; Zidane, L. Plant-Derived Natural Products: A Source for Drug Discovery and Development. Drugs Drug Candidates 2024, 3, 184–207. [Google Scholar] [CrossRef]
  162. Thomford, N.E.; Senthebane, D.A.; Rowe, A.; Munro, D.; Seele, P.; Maroyi, A.; Dzobo, K. Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery. Int. J. Mol. Sci. 2018, 19, 1578. [Google Scholar] [CrossRef]
  163. Atanasov, A.G.; Zotchev, S.B.; Dirsch, V.M. International Natural Product Sciences Taskforce; Supuran CT. Natural products in drug discovery: Advances and opportunities. Nat. Rev. Drug Discov. 2021, 20, 200–216. [Google Scholar] [CrossRef] [PubMed]
  164. Kanlayavattanakul, M.; Khongkow, M.; Klinngam, W.; Chaikul, P.; Lourith, N.; Chueamchaitrakun, P. Recent insights into catechins-rich Assam tea extract for photoaging and senescent ageing. Sci. Rep. 2024, 14, 2253. [Google Scholar] [CrossRef]
  165. Wu, J.; Bai, Q.; Chen, J.; Yang, Z.; Zhu, X. Systemic Analyses of Anti-Cell-Senescence Active Compounds in Camellia Sect. Chrysantha Chang and Their Mechanisms. Plants 2024, 13, 2139. [Google Scholar] [CrossRef] [PubMed]
  166. Chiva-Blanch, G.; Badimon, L. Effects of Polyphenol Intake on Metabolic Syndrome: Current Evidences from Human Trials. Oxid. Med. Cell Longev. 2017, 2017, 5812401. [Google Scholar] [CrossRef] [PubMed]
  167. West, T.; Atzeva, M.; Holtzman, D.M. Pomegranate polyphenols and resveratrol protect the neonatal brain against hypoxic-ischemic injury. Dev. Neurosci. 2007, 29, 363–372. [Google Scholar] [CrossRef]
  168. Kampa, M.; Nifli, A.P.; Notas, G.; Castanas, E. Polyphenols and cancer cell growth. Rev. Physiol. Biochem. Pharmacol. 2007, 159, 79–113. [Google Scholar] [CrossRef]
  169. Cyboran-Mikołajczyk, S.; Matczak, K.; Olchowik-Grabarek, E.; Sękowski, S.; Nowicka, P.; Krawczyk-Łebek, A.; Kostrzewa-Susłow, E. The influence of the chlorine atom on the biological activity of 2′-hydroxychalcone in relation to the lipid phase of biological membranes—Anticancer and antimicrobial activity. Chem. Biol. Interact. 2024, 398, 111082. [Google Scholar] [CrossRef]
  170. Filipe, H.A.L.; Sousa, C.; Marquês, J.T.; Vila-Viçosa, D.; de Granada-Flor, A.; Viana, A.S.; Santos, M.S.C.S.; Machuqueiro, M.; de Almeida, R.F.M. Differential targeting of membrane lipid domains by caffeic acid and its ester derivatives. Free Radic. Biol. Med. 2018, 115, 232–245. [Google Scholar] [CrossRef]
  171. Efimova, S.S.; Martynyuk, V.A.; Kozina, N.D.; Kirila, T.Y.; Filippov, A.P.; Ostroumova, O.S. Complexes of star-shaped block copolymers of poly(2-alkyl-2-oxazine)s and curcumin can affect lipid bilayers mimicking biomembranes. Biochim. Biophys. Acta Biomembr. 2025, 1867, 184443. [Google Scholar] [CrossRef]
  172. Estronca, L.M.; Moreno, M.J.; Abreu, M.S.; Melo, E.; Vaz, W.L. Solubility of amphiphiles in membranes: Influence of phase properties and amphiphile head group. Biochem. Biophys. Res. Commun. 2002, 296, 596–603. [Google Scholar] [CrossRef][Green Version]
  173. Efimova, S.S.; Ostroumova, O.S. Membrane dipole potential: Modification methods and consequences for ion channels incorporation in the membrane. Cell Tissue Biol. 2024, 18, 602–631. [Google Scholar] [CrossRef]
  174. Redford, K.E.; Abbott, G.W. The ubiquitous flavonoid quercetin is an atypical KCNQ potassium channel activator. Commun. Biol. 2020, 3, 356. [Google Scholar] [CrossRef] [PubMed]
  175. Saponara, S.; Fusi, F.; Iovinelli, D.; Ahmed, A.; Trezza, A.; Spiga, O.; Sgaragli, G.; Valoti, M. Flavonoids and hERG channels: Friends or foes? Eur. J. Pharmacol. 2021, 899, 174030. [Google Scholar] [CrossRef] [PubMed]
  176. Marunaka, Y. Actions of quercetin, a flavonoid, on ion transporters: Its physiological roles. Ann. N Y Acad Sci. 2017, 1398, 142–151. [Google Scholar] [CrossRef]
  177. Richter-Laskowska, M.; Trybek, P.; Delfino, D.V.; Wawrzkiewicz-Jałowiecka, A. Flavonoids as Modulators of Potassium Channels. Int. J. Mol. Sci. 2023, 24, 1311. [Google Scholar] [CrossRef]
  178. Kicinska, A.; Kampa, R.P.; Daniluk, J.; Sek, A.; Jarmuszkiewicz, W.; Szewczyk, A.; Bednarczyk, P. Regulation of the Mitochondrial BKCa Channel by the Citrus Flavonoid Naringenin as a Potential Means of Preventing Cell Damage. Molecules 2020, 25, 3010. [Google Scholar] [CrossRef]
  179. Koh, D.S.; Reid, G.; Vogel, W. Activating effect of the flavonoid phloretin on Ca(2+)-activated K+ channels in myelinated nerve fibers of Xenopus laevis [corrected]. Neurosci. Lett. 1994, 165, 167–170. [Google Scholar] [CrossRef] [PubMed]
  180. Scholz, E.P.; Zitron, E.; Katus, H.A.; Karle, C.A. Cardiovascular ion channels as a molecular target of flavonoids. Cardiovasc. Ther. 2010, 28, e46–e52. [Google Scholar] [CrossRef]
  181. Wallace, C.H.; Baczkó, I.; Jones, L.; Fercho, M.; Light, P.E. Inhibition of cardiac voltage-gated sodium channels by grape polyphenols. Br. J. Pharmacol. 2006, 149, 657–665. [Google Scholar] [CrossRef]
  182. Pyle, L.C.; Fulton, J.C.; Sloane, P.A.; Backer, K.; Mazur, M.; Prasain, J.; Barnes, S.; Clancy, J.P.; Rowe, S.M. Activation of the cystic fibrosis transmembrane conductance regulator by the flavonoid quercetin: Potential use as a biomarker of ΔF508 cystic fibrosis transmembrane conductance regulator rescue. Am. J. Respir. Cell Mol. Biol. 2010, 43, 607–616. [Google Scholar] [CrossRef]
  183. Goutman, J.D.; Waxemberg, M.D.; Doñate-Oliver, F.; Pomata, P.E.; Calvo, D.J. Flavonoid modulation of ionic currents mediated by GABA(A) and GABA(C) receptors. Eur. J. Pharmacol. 2003, 461, 79–87. [Google Scholar] [CrossRef]
  184. Zahra, M.; Abrahamse, H.; George, B.P. Flavonoids: Antioxidant Powerhouses and Their Role in Nanomedicine. Antioxidants 2024, 13, 922. [Google Scholar] [CrossRef]
  185. Hendrich, A.B. Flavonoid-membrane interactions: Possible consequences for biological effects of some polyphenolic compounds. Acta Pharmacol. Sin. 2006, 27, 27–40. [Google Scholar] [CrossRef]
  186. Męczarska, K.; Cyboran-Mikołajczyk, S.; Solarska-Ściuk, K.; Oszmiański, J.; Siejak, K.; Bonarska-Kujawa, D. Protective Effect of Field Horsetail Polyphenolic Extract on Erythrocytes and Their Membranes. Int. J. Mol. Sci. 2025, 26, 3213. [Google Scholar] [CrossRef] [PubMed]
  187. Kaźmierczak, T.; Cyboran-Mikołajczyk, S.; Trochanowska-Pauk, N.; Walski, T.; Nowicka, P.; Bonarska-Kujawa, D. Insights on the Mechanisms of the Protective Action of Naringenin, Naringin and Naringin Dihydrochalcone on Blood Cells in Terms of Their Potential Anti-Atherosclerotic Activity. Molecules 2025, 30, 547. [Google Scholar] [CrossRef] [PubMed]
  188. Kim, K.Y.; Blatt, L.; Taylor, M.W. The effects of interferon on the expression of human papillomavirus oncogenes. J. Gen. Virol. 2000, 81, 695–700. [Google Scholar] [CrossRef]
  189. Stenberg, T. Studies of the liver function in experimental burns. Iv. The radioiodine rose bengal (rirb) test in the burned rabbit. Acta Chir. Scand. 1964, 127, 367–378. [Google Scholar]
  190. Tsymbulskaya, M.V.; Antonenko, Y.N.; Tropsha, A.E.; Yaguzhinsky, L.S. Iodine-containing hormones—Dipole modifiers of phospholipid membranes. Biophysics 1984, 29, 801–805. [Google Scholar]
  191. Davis, P.J.; Goglia, F.; Leonard, J.L. Nongenomic actions of thyroid hormone. Nat. Rev. Endocrinol. 2016, 12, 111–121. [Google Scholar] [CrossRef]
  192. Sakaguchi, Y.; Cui, G.; Sen, L. Acute effects of thyroid hormone on inward rectifier potassium channel currents in guinea pig ventricular myocytes. Endocrinology 1996, 137, 4744–4751. [Google Scholar] [CrossRef][Green Version]
  193. Lin, H.Y.; Davis, F.B.; Luidens, M.K.; Mousa, S.A.; Cao, J.H.; Zhou, M.; Davis, P.J. Molecular basis for certain neuroprotective effects of thyroid hormone. Front. Mol. Neurosci. 2011, 4, 29. [Google Scholar] [CrossRef]
  194. Isse, B.; Fidelio, G.; Farías, R.N. Thyroid hormones affect the membrane dipolar organization. Is it a general event in their non-genomic action? J. Membr. Biol. 2003, 191, 209–213. [Google Scholar] [CrossRef] [PubMed]
  195. Kato, H.; Komagoe, K.; Nakanishi, Y.; Inoue, T.; Katsu, T. Xanthene dyes induce membrane permeabilization of bacteria and erythrocytes by photoinactivation. Photochem. Photobiol. 2012, 88, 423–431. [Google Scholar] [CrossRef] [PubMed]
  196. Netala, V.R.; Ghosh, S.B.; Bobbu, P.; Anitha, D.; Tartte, V. Triterpenoid saponins: A review on biosynthesis, applications and mechanism of their action. Int. J. Pharm. Pharm. Sci. 2015, 7, 24–28. [Google Scholar]
  197. Yan, L.L.; Zhang, Y.J.; Gao, W.Y.; Man, S.L.; Wang, Y. In vitro and in vivo anticancer activity of steroid saponins of paris polyphylla var. Yunnanensis Exp. Oncol. 2009, 31, 27–32. [Google Scholar] [CrossRef] [PubMed]
  198. Gestetner, B.; Assa, Y.; Henis, Y.; Tencer, Y.; Rotman, M.; Birk, Y.; Bondi, A. Interaction of leucerne saponins with steroids. Biochim. Biophys. Acta 1972, 270, 181–187. [Google Scholar] [CrossRef]
  199. Reed, J.; Orme, A.; El-Demerdash, A.; Owen, C.; Martin, L.B.B.; Misra, R.C.; Kikuchi, S.; Rejzek, M.; Martin, A.C.; Harkess, A.; et al. Elucidation of the pathway for biosynthesis of saponin adjuvants from the soapbark tree. Science 2023, 379, 1252–1264. [Google Scholar] [CrossRef]
  200. Ou, B.S.; Baillet, J.; Filsinger Interrante, M.V.; Adamska, J.Z.; Zhou, X.; Saouaf, O.M.; Yan, J.; Klich, J.H.; Jons, C.K.; Meany, E.L.; et al. Saponin nanoparticle adjuvants incorporating Toll-like receptor agonists drive distinct immune signatures and potent vaccine responses. Sci. Adv. 2024, 10, eadn7187. [Google Scholar] [CrossRef]
  201. Stertman, L.; Palm, A.E.; Zarnegar, B.; Carow, B.; Lunderius Andersson, C.; Magnusson, S.E.; Carnrot, C.; Shinde, V.; Smith, G.; Glenn, G.; et al. The Matrix-M™ adjuvant: A critical component of vaccines for the 21st century. Hum. Vaccin. Immunother. 2023, 19, 2189885. [Google Scholar] [CrossRef]
  202. Han, Y.; Sheng, W.; Liu, X.; Liu, H.; Jia, X.; Li, H.; Wang, C.; Wang, B.; Hu, T.; Ma, Y. Glycyrrhizin ameliorates colorectal cancer progression by regulating NHEJ pathway through inhibiting HMGB1-induced DNA damage response. Sci. Rep. 2024, 14, 24948. [Google Scholar] [CrossRef]
  203. Xiao, X.; Gao, C. Saikosaponins Targeting Programmed Cell Death as Anticancer Agents: Mechanisms and Future Perspectives. Drug Des. Devel. Ther. 2024, 18, 3697–3714. [Google Scholar] [PubMed]
  204. Yang, Y.; Nan, Y.; Du, Y.; Liu, W.; Ning, N.; Chen, G.; Gu, Q.; Yuan, L. Ginsenosides in cancer: Proliferation, metastasis, and drug resistance. Biomed. Pharmacother. 2024, 177, 117049. [Google Scholar] [CrossRef] [PubMed]
  205. Zhou, Y.; Farooqi, A.A.; Xu, B. Comprehensive review on signaling pathways of dietary saponins in cancer cells suppression. Crit. Rev. Food Sci. Nutr. 2023, 63, 4325–4350. [Google Scholar] [CrossRef] [PubMed]
  206. Man, S.; Gao, W.; Zhang, Y.; Huang, L.; Liu, C. Chemical study and medical application of saponins as anti-cancer agents. Fitoterapia 2010, 81, 703–714. [Google Scholar] [CrossRef]
  207. Shakurova, E.; Efimova, S.; Ostroumova, O.; Parfenova, L. One-pot synthesis of quaternary pyridinium salts of lupane triterpenoids and their antimicrobial properties. New J. Chem. 2023, 47, 3347–3355. [Google Scholar] [CrossRef]
  208. Chun, Y.S.; Shin, S.; Kim, Y.; Cho, H.; Park, M.K.; Kim, T.W.; Voronov, S.V.; Di Paolo, G.; Suh, B.C.; Chung, S. Cholesterol modulates ion channels via down-regulation of phosphatidylinositol 4,5-bisphosphate. J. Neurochem. 2010, 112, 1286–1294. [Google Scholar] [CrossRef]
  209. Vaithianathan, T.; Schneider, E.H.; Bukiya, A.N.; Dopico, A.M. Cholesterol and PIP2 Modulation of BKCa Channels. Adv. Exp. Med. Biol. 2023, 1422, 217–243. [Google Scholar] [CrossRef]
  210. Li, J.; Xie, Z.Z.; Tang, Y.B.; Zhou, J.G.; Guan, Y.Y. Ginsenoside-Rd, a purified component from panax notoginseng saponins, prevents atherosclerosis in apoE knockout mice. Eur. J. Pharmacol. 2011, 652, 104–110. [Google Scholar] [CrossRef]
  211. Kanmani Bharathi, J.; Prakash, M.A.S. Estimation of total flavonoids, phenols, alkaloids, tannins and in vitro antioxidant activity of Costus pictus D. Don. ex. Lindl. and Dodonaea viscosa (L.) Jacq. leaf extracts. Chem. Pap. 2025, 79, 545–559. [Google Scholar] [CrossRef]
  212. Tsuchiya, H. Anesthetic Agents of Plant Origin: A Review of Phytochemicals with Anesthetic Activity. Molecules 2017, 22, 1369. [Google Scholar] [CrossRef] [PubMed]
  213. Qiu, S.; Sun, H.; Zhang, A.H.; Xu, H.Y.; Yan, G.L.; Han, Y.; Wang, X.J. Natural alkaloids: Basic aspects, biological roles, and future perspectives. Chin. J. Nat. Med. 2014, 12, 401–406. [Google Scholar] [CrossRef] [PubMed]
  214. Salimova, E.V.; Mozgovoj, O.S.; Efimova, S.S.; Ostroumova, O.S.; Parfenova, L.V. 3-Amino-substituted analogues of fusidic acid as membrane-active antibacterial compounds. Membranes 2023, 13, 309. [Google Scholar] [CrossRef]
  215. Lundbaek, J.A.; Birn, P.; Tape, S.E.; Toombes, G.E.; Søgaard, R.; Koeppe, R.E., II; Gruner, S.M.; Hansen, A.J.; Andersen, O.S. Capsaicin regulates voltage-dependent sodium channels by altering lipid bilayer elasticity. Mol. Pharmacol. 2005, 68, 680–689. [Google Scholar] [CrossRef]
  216. Ingólfsson, H.I.; Thakur, P.; Herold, K.F.; Hobart, E.A.; Ramsey, N.B.; Periole, X.; de Jong, D.H.; Zwama, M.; Yilmaz, D.; Hall, K.; et al. Phytochemicals perturb membranes and promiscuously alter protein function. ACS Chem. Biol. 2014, 9, 1788–1798. [Google Scholar] [CrossRef] [PubMed]
  217. Schmidt, A.; Alsop, R.J.; Rimal, R.; Lenzig, P.; Joussen, S.; Gervasi, N.N.; Khondker, A.; Gründer, S.; Rheinstädter, M.C.; Wiemuth, D. Modulation of DEG/ENaCs by Amphiphiles Suggests Sensitivity to Membrane Alterations. Biophys. J. 2018, 114, 1321–1335. [Google Scholar] [CrossRef]
  218. Søgaard, R.; Werge, T.M.; Bertelsen, C.; Lundbye, C.; Madsen, K.L.; Nielsen, C.H.; Lundbaek, J.A. GABA(A) receptor function is regulated by lipid bilayer elasticity. Biochemistry 2006, 45, 13118–13129. [Google Scholar] [CrossRef]
  219. Aréchiga-Figueroa, I.A.; Morán-Zendejas, R.; Delgado-Ramírez, M.; Rodríguez-Menchaca, A.A. Phytochemicals genistein and capsaicin modulate Kv2.1 channel gating. Pharmacol. Rep. 2017, 69, 1145–1153. [Google Scholar] [CrossRef]
  220. Hille, B. Local anesthetics: Hydrophilic and hydrophobic pathways for the drug-receptor reaction. J. Gen. Physiol. 1977, 69, 497–515. [Google Scholar] [CrossRef]
  221. Ragsdale, D.S.; McPhee, J.C.; Scheuer, T.; Catterall, W.A. Molecular determinants of state-dependent block of Na+ channels by local anesthetics. Science 1994, 265, 1724–1728. [Google Scholar] [CrossRef]
  222. Wright, S.N.; Wang, S.Y.; Xiao, Y.F.; Wang, G.K. State-dependent cocaine block of sodium channel isoforms, chimeras, and channels coexpressed with the beta1 subunit. Biophys. J. 1999, 76, 233–245. [Google Scholar] [CrossRef] [PubMed]
  223. Yarov-Yarovoy, V.; Brown, J.; Sharp, E.M.; Clare, J.J.; Scheuer, T.; Catterall, W.A. Molecular determinants of voltage-dependent gating and binding of pore-blocking drugs in transmembrane segment IIIS6 of the Na(+) channel alpha subunit. J. Biol. Chem. 2001, 276, 20–27. [Google Scholar] [CrossRef] [PubMed]
  224. Janoff, A.S.; Pringle, M.J.; Miller, K.W. Correlation of general anesthetic potency with solubility in membranes. Biochim. Biophys. Acta 1981, 649, 125–128. [Google Scholar] [CrossRef] [PubMed]
  225. Li, Y.; Xu, J.; Xu, Y.; Zhao, X.Y.; Liu, Y.; Wang, J.; Wang, G.M.; Lv, Y.T.; Tang, Q.Y.; Zhang, Z. Regulatory Effect of General Anesthetics on Activity of Potassium Channels. Neurosci. Bull. 2018, 34, 887–900. [Google Scholar] [CrossRef] [PubMed]
  226. Zapata-Morin, P.A.; Sierra-Valdez, F.J.; Ruiz-Suárez, J.C. The interaction of local anesthetics with lipid membranes. J. Mol. Graph. Model. 2014, 53, 200–205. [Google Scholar] [CrossRef] [PubMed]
  227. Limoncella, S.; Lazzaretti, C.; Paradiso, E.; D’Alessandro, S.; Barbagallo, F.; Pacifico, S.; Guerrini, R.; Tagliavini, S.; Trenti, T.; Santi, D.; et al. Phosphodiesterase (PDE) 5 inhibitors sildenafil, tadalafil and vardenafil impact cAMP-specific PDE8 isoforms-linked second messengers and steroid production in a mouse Leydig tumor cell line. Mol. Cell Endocrinol. 2022, 542, 111527. [Google Scholar] [CrossRef] [PubMed]
  228. Kukreja, R.C.; Salloum, F.N.; Das, A. Role of cGMP Signaling and Phosphodiesterase-5 inhibitors in Cardioprotection. J. Am. Coll. Cardiol. 2012, 59, 1921–1927. [Google Scholar] [CrossRef]
  229. Zakharova, A.A.; Efimova, S.S.; Ostroumova, O.S. Phosphodiesterase Type 5 Inhibitors Greatly Affect Physicochemical Properties of Model Lipid Membranes. Membranes 2021, 11, 893. [Google Scholar] [CrossRef]
  230. Pușcașu, C.; Zanfirescu, A.; Negreș, S.; Șeremet, O.C. Exploring the Multifaceted Potential of Sildenafil in Medicine. Medicina 2023, 59, 2190. [Google Scholar] [CrossRef]
  231. Malykhina, A.I.; Efimova, S.S.; Ostroumova, O.S. Membrane-Mediated Action of Phosphodiesterase 5 Inhibitors. Pharmaceutics 2025, 17, 563. [Google Scholar] [CrossRef]
  232. Benza, R.L.; Grünig, E.; Sandner, P.; Stasch, J.P.; Simonneau, G. The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: From PDE5 to soluble guanylate cyclase. Eur. Respir. Rev. 2024, 33, 230183. [Google Scholar] [CrossRef] [PubMed]
  233. Gregory, P. Classification of dyes by chemical structure. In The Chemistry and Application of Dyes; Waring, D.H., Hallas, G., Eds.; Plenum Press: New York, NY, USA, 1990; pp. 17–47. [Google Scholar]
  234. Fluhler, E.; Burnham, V.G.; Loew, L.M. Spectra, membrane binding, and potentiometric responses of new charge shift probes. Biochemistry 1985, 24, 5749–5755. [Google Scholar] [CrossRef] [PubMed]
  235. Grinvald, A.; Hildesheim, R.; Farber, I.C.; Anglister, L. Improved fluorescent probes for the measurement of rapid changes in membrane potential. Biophys. J. 1982, 39, 301–308. [Google Scholar] [CrossRef]
  236. Loew, L.M.; Simpson, L.L. Charge-shift probes of membrane potential: A probable electrochromic mechanism for p-aminostyrylpyridinium probes on a hemispherical lipid bilayer. Biophys. J. 1981, 34, 353–365. [Google Scholar] [CrossRef]
  237. Waggoner, A.S. Dye indicators of membrane potential. Annu. Rev. Biophys. Bioeng. 1979, 8, 47–68. [Google Scholar] [CrossRef] [PubMed]
  238. O’Connor, N.; Silver, R.B. Ratio imaging: Practical considerations for measuring intracellular Ca2+ and pH in living cells. Methods Cell Biol. 2013, 114, 387–406. [Google Scholar] [CrossRef]
  239. Malkov, D.Y.; Sokolov, V.S. Fluorescent styryl dyes of the RH series affect a potential drop on the membrane/solution boundary. Biochim. Biophys. Acta 1996, 1278, 197–204. [Google Scholar]
  240. Passechnik, V.I.; Sokolov, V.S. Estimation of electrochrome dyes position in the bilayer through the 2nd harmonic of capacitive current. Bioelectrochemistry 2002, 55, 47–51. [Google Scholar] [CrossRef]
  241. Fedosova, N.U.; Cornelius, F.; Klodos, I. Fluorescent styryl dyes as probes for Na,K-ATPase reaction mechanism: Significance of the charge of the hydrophilic moiety of RH dyes. Biochemistry 1995, 34, 16806–16814. [Google Scholar] [CrossRef]
  242. Chernov, N.; Shutov, R.; Barygin, O.; Dron, M.; Starova, G.; Kuz’mich, N.; Yakovlev, I. Synthesis of chromone-containing allylmorpholines through a Morita-Baylis-Hillman-type reaction. Eur. J. Org. Chem. 2018, 2018, 6304–6313. [Google Scholar] [CrossRef]
  243. Degorce, S.L.; Bodnarchuk, M.S.; Cumming, I.A.; Scott, J.S. Lowering lipophilicity by adding carbon: One-carbon bridges of morpholines and piperazines. J. Med. Chem. 2018, 61, 8934–8943. [Google Scholar] [CrossRef]
  244. Efimova, S.S.; Martynyuk, V.A.; Zakharova, A.A.; Yudintceva, N.M.; Chernov, N.M.; Yakovlev, I.P.; Ostroumova, O.S. Chromone-Containing Allylmorpholines Influence Ion Channels in Lipid Membranes via Dipole Potential and Packing Stress. Int. J. Mol. Sci. 2022, 23, 11554. [Google Scholar] [CrossRef]
  245. Ahmad, S.; Alam, M.Z.; Salma, U.; Mohasin, M.; Rahaman, P.F.; Parveen, H.; Khan, S.A. A review on recent progress in synthesis and biological activities of thiadiazole and its derivatives. J. Mol. Struct. 2024, 1312, 138438. [Google Scholar] [CrossRef]
  246. Atmaram, U.A.; Roopan, S.M. Biological activity of oxadiazole and thiadiazole derivatives. Appl. Microbiol. Biotechnol. 2022, 106, 3489–3505. [Google Scholar] [CrossRef] [PubMed]
  247. Kalogirou, A.S.; Oh, H.J.; Asquith, C.R.M. The Synthesis and Biological Applications of the 1,2,3-Dithiazole Scaffold. Molecules 2023, 28, 3193. [Google Scholar] [CrossRef]
  248. Zumla, A.I.; Gillespie, S.H.; Hoelscher, M.; Philips, P.P.; Cole, S.T.; Abubakar, I.; McHugh, T.D.; Schito, M.; Maeurer, M.; Nunn, A.J. New antituberculosis drugs, regimens, and adjunct therapies: Needs, advances, and future prospects. Lancet Infect Dis. 2014, 14, 327–340. [Google Scholar] [CrossRef] [PubMed]
  249. Grekhnev, D.A.; Novikova, I.V.; Krisanova, A.V.; Yuskovets, V.N.; Chernov, N.M.; Yakovlev, I.P.; Kaznacheyeva, E.V.; Vigont, V.A. Dithiadiazole derivative 3-(4-nitrophenyl)-5-phenyl-3H-1,2,3,4-dithiadiazole-2-oxide—Novel modulator of store-operated calcium entry. Biochem. Biophys. Res. Commun. 2022, 626, 38–43. [Google Scholar] [CrossRef] [PubMed]
  250. Novikova, I.V.; Grekhnev, D.A.; Oshkolova, A.; Nomerovskaya, M.A.; Kolesnikov, D.O.; Krisanova, A.V.; Yuskovets, V.N.; Chernov, N.M.; Yakovlev, I.P.; Kaznacheyeva, E.V.; et al. 1,2,3,4-dithiadiazole derivatives as a novel class of calcium signaling modulators. Biochem. Biophys. Res. Commun. 2024, 691, 149333. [Google Scholar] [CrossRef]
  251. Zakharova, A.A.; Efimova, S.S.; Yuskovets, V.N.; Yakovlev, I.P.; Sarkisyan, Z.M.; Ostroumova, O.S. 1,3-Thiazine, 1,2,3,4-Dithiadiazole, and Thiohydrazide Derivatives Affect Lipid Bilayer Properties and Ion-Permeable Pores Induced by Antifungals. Front. Cell Dev. Biol. 2020, 8, 535. [Google Scholar] [CrossRef]
  252. Grekhnev, D.A.; Novikova, I.V.; Yuskovets, V.N.; Chernov, N.M.; Yakovlev, I.P.; Skopin, A.Y.; Kaznacheyeva, E.V.; Vigont, V.A. 1,2,3,4-Dithiadiazole Derivative 3-(4-Nitrophenyl)-5-Phenyl-3H-1,2,3,4-Dithiadiazole-2-Oxide Affects Both STIM1- and STIM2-Dependent Store-Operated Calcium Channels. Bull. Exp. Biol. Med. 2025, 179, 287–291. [Google Scholar] [CrossRef]
  253. Zlodeeva, P.D.; Shekunov, E.V.; Ostroumova, O.S.; Efimova, S.S. The degree of hydroxylation of phenolic rings determines the ability of flavonoids and stilbenes to inhibit calcium-mediated membrane fusion. Nutrients 2023, 15, 1121. [Google Scholar] [CrossRef] [PubMed]
  254. Efimova, S.S.; Zakharova, A.A.; Chernyshova, D.N.; Ostroumova, O.S. The specific effect of grapefruit seeds, sea buckthorn leaves and chaga extracts on the properties of model lipid membranes. Cell Tissue Biol. 2023, 17, 96–104. [Google Scholar] [CrossRef]
  255. Efimova, S.S.; Malykhina, A.I.; Ostroumova, O.S. Triggering the amphotericin B pore-forming activity by phytochemicals. Membranes 2023, 13, 670. [Google Scholar] [CrossRef]
  256. Jain, M.K.; Wu, N.M. Effect of small molecules on the dipalmitoyl lecithin liposomal bilayer: III. Phase transition in lipid bilayer. J. Membr. Biol. 1977, 34, 157–201. [Google Scholar] [CrossRef]
  257. Malykhina, A.I.; Ostroumova, O.S.; Efimova, S.S. Assessing the Influence of Xanthene Dyes on the Physical Properties of Lipid Membranes Using a Molecular Dynamics Simulation. Cell Tissue Biol. 2025, 19, 374–379. [Google Scholar] [CrossRef]
  258. Duong, M.T.T.; Long, N.N.; Son, P.H.; Van, T.T.H.; Bach, L.G.; Long, P.Q.; Long, P.Q.; Hai, H.V.; Lam, D.T.; Minh, P.T.H.; et al. Potential inhibitory activities of phytoconstituents in Salvia miltiorrhiza against coronary heart disease drug targets using docking and ADMET studies. Vietnam. J. Sci. Technol. 2024, 62, 648–659. [Google Scholar] [CrossRef]
  259. Mohan, S.; Hobani, Y.H.; Shaheen, E.; Abou-Elhamd, A.S.; Abdelhaleem, A.; Alhazmi, H.A.; Abdelwahab, S.I. Ameliorative effect of Boesenbergin A, a chalcone isolated from Boesenbergia rotunda (Fingerroot) on oxidative stress and inflammation in ethanol-induced gastric ulcer in vivo. J. Ethnopharmacol. 2020, 261, 113104. [Google Scholar] [CrossRef]
  260. Lu, Y.; Zhang, Y.Y.; Hu, Y.C.; Lu, Y.H. Protective effects of 2′,4′-dihydroxy-6′-methoxy-3′,5′-dimethylchalcone against hydrogen peroxide-induced oxidative stress in hepatic L02 cell. Arch. Pharm. Res. 2014, 37, 1211–1218. [Google Scholar] [CrossRef]
  261. Ha, L.M.; Que, D.T.N.; Huyen, D.T.T.; Long, P.Q.; Dat, N.T. Toxicity, analgesic and anti-inflammatory activities of tectorigenin. Immunopharmacol. Immunotoxicol. 2013, 35, 336–340. [Google Scholar] [CrossRef] [PubMed]
  262. Cuong, N.M.; Khanh, P.N.; Nhung, L.T.H.; Ha, N.X.; Huong, T.T.; Bauerova, K.; Kim, Y.H.; Tung, D.D.; Thuy, T.T.; Anh, N.T.H. Acetylcholinesterase inhibitory activities of some flavonoids from the root bark of Pinus krempfii Lecomte: In vitro and in silico study. J. Biomol. Struct. Dyn. 2024, 42, 4888–4901. [Google Scholar] [CrossRef] [PubMed]
  263. Nguyen, A.-T.; Pham, M.Q.; Nguyen, P.-H.; To, D.C.; Dang, N.Q.; Nguyen, T.-H.; Nguyen, H.-T.; Nguyen, T.-D.; Pham, K.-H.T.; Tran, M.-H. Identification of natural curcumins as potential dual inhibitors of PTP1B and α-glucosidase through experimental and computational study. Kuwait J. Sci. 2025, 52, 100312. [Google Scholar] [CrossRef]
  264. Van, N.T.H.; Bach, P.C.; Ich, C.T.; Phuong, D.L.; Thanh, L.T.; Toan, T.Q.; Long, P.Q. Flavonoids isolated from the flowers of Camellia chrysantha. Vietnam. J. Sci. Technol. 2019, 57, 287–293. [Google Scholar] [CrossRef]
  265. Cuong, N.M.; Khanh, P.N.; Duc, H.V.; Huong, T.T.; Kim, Y.C.; Long, P.Q.; Kim, Y.H. Flavonoids and triterpenoids from Callistemon citrinus and their inhibitory effect on no production in LPS-stimulated RAW264. 7 macrophages. Vietnam. J. Sci. Technol. 2016, 54, 214–223. [Google Scholar] [CrossRef]
  266. Pham, M.Q.; Le, T.T.H.; Do, T.L.; Pham, T.H.M.; Pham, Q.L.; Nguyen, P.H.; To, D.C. Identification of Cytotoxic Constituents from the Whole Plant of Isodon ternifolius. Nat. Prod. Commun. 2020, 15, 1934578X2095324. [Google Scholar] [CrossRef]
  267. Phuong, N.T.; Ngoc, D.B.; Viet, N.M.; Anh, N.T.; Dat, N.T.; Long, P.Q. Acontribution to study chemical constituents of Desmodium gangeticum of Viet Nam. Vietnam. J. Sci. Technol. 2019, 57, 1–6. [Google Scholar] [CrossRef]
  268. Hung, N.P.; Thuan, H.D.; Trung, V.Q.; Long, P.Q. PTP1B inhibitory flavonols from Orthosiphon stamineus Benth. Vietnam. J. Chem. 2017, 55, 652. [Google Scholar]
  269. Ha, L.M.; Luyen, N.T.; Phuong, N.T.; Huyen, D.T.T.; Huong, L.M.; Quan, P.M.; Hiep, N.T.; Dat, N.T. Isoflavonoids from Desmodium heterophyllum Aerial Parts. Nat. Prod. Commun. 2018, 13, 699–700. [Google Scholar] [CrossRef]
  270. Duyen, N.T.; Vinh, L.B.; Phong, N.V.; Khoi, N.M.; Ha, D.T.; Long, P.Q.; Dung, L.V.; Hien, T.T.; Dat, N.T.; Lee, K.Y. Steroid glycosides isolated from Paris polyphylla var. chinensis aerial parts and paris saponin II induces G1/S-phase MCF-7 cell cycle arrest. Carbohydr. Res. 2022, 519, 108613. [Google Scholar] [CrossRef]
  271. Nguyen, H.T.; Tran, H.Q.; Nguyen, T.T.; Chau, V.M.; Bui, K.A.; Pham, Q.L.; Nguyen, M.C.; Kim, Y.H. Oleanolic triterpene saponins from the roots of Panax bipinnatifidus. Chem. Pharm. Bull. 2011, 59, 1417–1420. [Google Scholar] [CrossRef][Green Version]
  272. Van, N.T.; Vien, T.A.; Van Kiem, P.; Van Minh, C.; Nhiem, N.X.; Long, P.Q.; Anh, L.T.; Kim, N.; Park, S.; Kim, S.H. Chemical components from the leaves of Ardisia insularis and their cytotoxic activity. Arch. Pharm. Res. 2015, 38, 1926–1931. [Google Scholar] [CrossRef]
  273. Anh, L.T.T.; Son, N.T.; Van Tuyen, N.; Thuy, P.T.; Quan, P.M.; Ha, N.T.T.; Tra, N.T. Antioxidative and α-glucosidase inhibitory constituents of Polyscias guilfoylei: Experimental and computational assessments. Mol. Divers. 2022, 26, 229–243. [Google Scholar] [CrossRef] [PubMed]
  274. Chu, T.; Wang, Y.; Wang, S.; Li, J.; Li, Z.; Wei, Z.; Li, J.; Bian, Y. Kaempferol regulating macrophage foaming and atherosclerosis through Piezo1-mediated MAPK/NF-κB and Nrf2/HO-1 signaling pathway. J. Adv. Res. 2025, 75, 635–650. [Google Scholar] [CrossRef] [PubMed]
  275. Sinha, B.A.; Smejtek, P. Effect of 3-phenylindole on lipophilic ion and carrier-mediated ion transport across bilayer lipid membranes. J. Membr. Biol. 1983, 71, 119–130. [Google Scholar] [CrossRef]
  276. Reyes, J.; Benos, D.J. Changes in interfacial potentials induced by carbonylcyanide phenylhydrazone uncouplers: Possible role in inhibition of mitochondrial oxygen consumption and other transport processes. Membr. Biochem. 1984, 5, 243–268. [Google Scholar] [CrossRef]
  277. Luzardo, M.C.; Amalfa, F.; Nuñez, A.M.; Díaz, S.; Biondi De Lopez, A.C.; Disalvo, E.A. Effect of trehalose and sucrose on the hydration and dipole potential of lipid bilayers. Biophys. J. 2000, 78, 2452–2458. [Google Scholar] [CrossRef]
  278. Fonseca, A.C.; Frías, M.A.; Bouchet, A.M.; Jarmelo, S.; Simões, P.N.; Fausto, R.; Gil, M.H.; Lairion, F.; Disalvo, E.A. Role of guanidyl moiety in the insertion of arginine and Nalpha-benzoyl-L-argininate ethyl ester chloride in lipid membranes. J. Phys. Chem. B 2010, 114, 5946–5952. [Google Scholar] [CrossRef] [PubMed]
  279. Bordón, A.; Rodríguez, S.A.; Chaves, D.S.A.; Cutró, A.C.; Hollmann, A. Antimicrobial Action of Essential Oil of Tagetes minuta: Role of the Bacterial Membrane in the Mechanism of Action. Antibiotics 2025, 14, 632. [Google Scholar] [CrossRef]
  280. Salcedo, C.L.; Frías, M.A.; Cutro, A.C.; Nazareno, M.A.; Disalvo, E.A. Antiradical activity of gallic acid included in lipid interphases. Biochim. Biophys. Acta 2014, 1838, 2656–2661. [Google Scholar] [CrossRef]
  281. Sarkar, A.; Mitra, J.B.; Sharma, V.K.; Namboodiri, V.; Kumbhakar, M. Spectrally resolved single-molecule orientation imaging reveals a direct correspondence between the polarity and microviscosity experienced by nile red in supported lipid bilayer membranes. J. Phys. Chem. B 2025, 129, 2380–2391. [Google Scholar] [CrossRef]
  282. Bruhn, D.S.; Lomholt, M.A.; Khandelia, H. Quantifying the relationship between curvature and electric potential in lipid bilayers. J. Phys. Chem. B 2016, 120, 4812–4817. [Google Scholar] [CrossRef]
Figure 1. Schematic representation of the common existing methodological approaches to evaluate changes in the membrane dipole potential.
Figure 1. Schematic representation of the common existing methodological approaches to evaluate changes in the membrane dipole potential.
Biomolecules 16 00342 g001
Figure 4. The effects of thyroid hormones and xanthene dyes on the dipole potential of phosphocholine membranes. The mean maximum changes in the dipole potential (Δφd) are taken from [94,190]. The estimated Δφd values are derived by consolidating and averaging data from various cited sources, such as those provided for * tetraiodothyronine and triiodothyronine [94,190] and # Rose Bengal [94,190]. The deviation from the mean Δφd value observed in experiments is presented as an error bar, and it is taken from the corresponding reference for a given compound or represents the maximum difference between mean Δφd values from different cited studies. The column color depends on the strength of the dipole-modifying ability of the compound: black—negligible effect on φd (|Δφd| < 20 mV), blue—moderate dipole-modifying efficiency (−60 ≥ Δφd > −100 mV), and dark blue—significant decrease in φd (Δφd ≤ −100 mV).
Figure 4. The effects of thyroid hormones and xanthene dyes on the dipole potential of phosphocholine membranes. The mean maximum changes in the dipole potential (Δφd) are taken from [94,190]. The estimated Δφd values are derived by consolidating and averaging data from various cited sources, such as those provided for * tetraiodothyronine and triiodothyronine [94,190] and # Rose Bengal [94,190]. The deviation from the mean Δφd value observed in experiments is presented as an error bar, and it is taken from the corresponding reference for a given compound or represents the maximum difference between mean Δφd values from different cited studies. The column color depends on the strength of the dipole-modifying ability of the compound: black—negligible effect on φd (|Δφd| < 20 mV), blue—moderate dipole-modifying efficiency (−60 ≥ Δφd > −100 mV), and dark blue—significant decrease in φd (Δφd ≤ −100 mV).
Biomolecules 16 00342 g004
Figure 5. The relationship between the structure of thyroid hormones (a) and xanthene dyes (b) and their dipole-modifying ability. The logD, μ, and Δφd values are presented according to [94,173].
Figure 5. The relationship between the structure of thyroid hormones (a) and xanthene dyes (b) and their dipole-modifying ability. The logD, μ, and Δφd values are presented according to [94,173].
Biomolecules 16 00342 g005
Figure 6. The effect of saponins and related compounds on the dipole potential of phosphocholine membranes. The mean maximum changes in the dipole potential (Δφd) are taken from [152,207]. The deviation from the mean Δφd value observed in experiments is presented as an error bar, and it is taken from the corresponding reference for a given compound. The column color depends on the strength of the dipole-modifying ability of the compound: black—negligible effect on φd (|Δφd| < 20 mV), cyan—slight decrease in φd (−20 ≥ Δφd > −60 mV).
Figure 6. The effect of saponins and related compounds on the dipole potential of phosphocholine membranes. The mean maximum changes in the dipole potential (Δφd) are taken from [152,207]. The deviation from the mean Δφd value observed in experiments is presented as an error bar, and it is taken from the corresponding reference for a given compound. The column color depends on the strength of the dipole-modifying ability of the compound: black—negligible effect on φd (|Δφd| < 20 mV), cyan—slight decrease in φd (−20 ≥ Δφd > −60 mV).
Biomolecules 16 00342 g006
Figure 7. The relationship between the structure of betulin derivatives and their dipole-modifying ability. The logD, μ, and Δφd values are presented according to [152,207].
Figure 7. The relationship between the structure of betulin derivatives and their dipole-modifying ability. The logD, μ, and Δφd values are presented according to [152,207].
Biomolecules 16 00342 g007
Figure 8. The influence of alkaloids and related compounds on the dipole potential of phosphocholine membranes is explored. The mean maximum changes in the dipole potential (Δφd) are taken from [138,151,214]. The deviation from the mean Δφd value observed in experiments is presented as an error bar; it is taken from the corresponding reference for a given compound. The column color depends on the strength of the dipole-modifying ability of the compound: black—negligible effect on φd (|Δφd| < 20 mV), cyan—slight decrease in φd (−20 ≥ Δφd > −60 mV), and dark bluesignificant decrease in φd (Δφd ≤ −100 mV).
Figure 8. The influence of alkaloids and related compounds on the dipole potential of phosphocholine membranes is explored. The mean maximum changes in the dipole potential (Δφd) are taken from [138,151,214]. The deviation from the mean Δφd value observed in experiments is presented as an error bar; it is taken from the corresponding reference for a given compound. The column color depends on the strength of the dipole-modifying ability of the compound: black—negligible effect on φd (|Δφd| < 20 mV), cyan—slight decrease in φd (−20 ≥ Δφd > −60 mV), and dark bluesignificant decrease in φd (Δφd ≤ −100 mV).
Biomolecules 16 00342 g008
Figure 9. The relationship between the structure of alkaloids and related compounds and their dipole-modifying ability: (a) xanthines; (b) capsaicin and dihydrocapsaicin; (c) spermin derivatives; (d) isoniazid derivatives. The logD, μ, and Δφd values are presented according to [138,151,214].
Figure 9. The relationship between the structure of alkaloids and related compounds and their dipole-modifying ability: (a) xanthines; (b) capsaicin and dihydrocapsaicin; (c) spermin derivatives; (d) isoniazid derivatives. The logD, μ, and Δφd values are presented according to [138,151,214].
Biomolecules 16 00342 g009
Figure 10. (a) The action of anesthetics on the dipole potential of phosphocholine membranes is explored. The mean maximum changes in the dipole potential (Δφd) are taken from [56,92,135]. ** The estimated Δφd value in the presence of lidocaine is derived by consolidating and averaging data from various cited sources [56,92]. The deviation from the mean value of Δφd observed in the experiment is presented as an error bar; it is taken from the corresponding reference for certain compounds or represents the maximum difference between the mean values of Δφd obtained in different cited studies. The color of the column depends on the strength of the dipole-modifying ability of the compound: redmoderate enhancement in φd (60 ≤ Δφd < 100 mV), pink—slight increase in φd (20 ≤ Δφd < 60 mV), black—negligible effect on φd (|Δφd| < 20 mV), cyan—slight decrease in φd (−20 ≥ Δφd > −60 mV), blue—moderate dipole-modifying efficiency (−60 ≥ Δφd > −100 mV). Inset—the chemical structure of articaine. (b) The relationship between the structure of general anesthetics and their dipole-modifying ability. The logD, μ, and Δφd values are presented according to [56,92,135] (nd—not determined).
Figure 10. (a) The action of anesthetics on the dipole potential of phosphocholine membranes is explored. The mean maximum changes in the dipole potential (Δφd) are taken from [56,92,135]. ** The estimated Δφd value in the presence of lidocaine is derived by consolidating and averaging data from various cited sources [56,92]. The deviation from the mean value of Δφd observed in the experiment is presented as an error bar; it is taken from the corresponding reference for certain compounds or represents the maximum difference between the mean values of Δφd obtained in different cited studies. The color of the column depends on the strength of the dipole-modifying ability of the compound: redmoderate enhancement in φd (60 ≤ Δφd < 100 mV), pink—slight increase in φd (20 ≤ Δφd < 60 mV), black—negligible effect on φd (|Δφd| < 20 mV), cyan—slight decrease in φd (−20 ≥ Δφd > −60 mV), blue—moderate dipole-modifying efficiency (−60 ≥ Δφd > −100 mV). Inset—the chemical structure of articaine. (b) The relationship between the structure of general anesthetics and their dipole-modifying ability. The logD, μ, and Δφd values are presented according to [56,92,135] (nd—not determined).
Biomolecules 16 00342 g010
Figure 11. (a) The effect of phosphodiesterase type 5 inhibitors on the dipole potential of phosphocholine membranes is explored. The mean maximum changes in dipole potential (Δφd) are taken from [229]. The deviation from the mean value of Δφd observed in the experiment is presented as an error bar; it is taken from [229]. The blue color of the columns corresponds to moderate dipole-diminishing efficiency of the compounds (−60 ≥ Δφd > −100 mV). (b) The relationship between the structure of compounds and their dipole-modifying ability. The logD, μ, and Δφd values are presented according to [229].
Figure 11. (a) The effect of phosphodiesterase type 5 inhibitors on the dipole potential of phosphocholine membranes is explored. The mean maximum changes in dipole potential (Δφd) are taken from [229]. The deviation from the mean value of Δφd observed in the experiment is presented as an error bar; it is taken from [229]. The blue color of the columns corresponds to moderate dipole-diminishing efficiency of the compounds (−60 ≥ Δφd > −100 mV). (b) The relationship between the structure of compounds and their dipole-modifying ability. The logD, μ, and Δφd values are presented according to [229].
Biomolecules 16 00342 g011
Figure 12. (a) The effects of styryl dyes on the dipole potential of phosphocholine membranes. The mean maximum changes in the dipole potential (Δφd) are derived by consolidating and averaging data from [149,239]. The deviation from the mean Δφd value observed in experiments is presented as an error bar; it is taken from the corresponding reference for a given compound or represents the maximum difference between mean Δφd values from different cited studies. The color of the column depends on the strength of the dipole-modifying ability of the compound: burgundy—significant increase in φd (Δφd ≥ 100 mV), red—moderate enlargement in φd (60 ≤ Δφd < 100 mV), and pink—slight increase in φd (20 ≤ Δφd < 60 mV). (b) The relationship between the structure of styryl dyes and their dipole-modifying ability. The logD, μ, and Δφd values are presented according to [149] (nd—not determined).
Figure 12. (a) The effects of styryl dyes on the dipole potential of phosphocholine membranes. The mean maximum changes in the dipole potential (Δφd) are derived by consolidating and averaging data from [149,239]. The deviation from the mean Δφd value observed in experiments is presented as an error bar; it is taken from the corresponding reference for a given compound or represents the maximum difference between mean Δφd values from different cited studies. The color of the column depends on the strength of the dipole-modifying ability of the compound: burgundy—significant increase in φd (Δφd ≥ 100 mV), red—moderate enlargement in φd (60 ≤ Δφd < 100 mV), and pink—slight increase in φd (20 ≤ Δφd < 60 mV). (b) The relationship between the structure of styryl dyes and their dipole-modifying ability. The logD, μ, and Δφd values are presented according to [149] (nd—not determined).
Biomolecules 16 00342 g012
Figure 13. The influence of chromonylallylmorpholines on the dipole potential of phosphocholine membranes is explored. The mean maximum changes in the dipole potential (Δφd) are taken from [244]. The deviation from the mean Δφd value observed in experiments is presented as an error bar. The color of the column depends on the strength of the dipole-modifying ability of the compound: pink—slight increase in φd (20 ≤ Δφd < 60 mV), cyan—slight decrease in φd (−20 ≥ Δφd > −60 mV), blue—moderate dipole-modifying efficiency (−60 ≥ Δφd > −100 mV), and dark blue—significant decrease in φd (Δφd ≤ −100 mV).
Figure 13. The influence of chromonylallylmorpholines on the dipole potential of phosphocholine membranes is explored. The mean maximum changes in the dipole potential (Δφd) are taken from [244]. The deviation from the mean Δφd value observed in experiments is presented as an error bar. The color of the column depends on the strength of the dipole-modifying ability of the compound: pink—slight increase in φd (20 ≤ Δφd < 60 mV), cyan—slight decrease in φd (−20 ≥ Δφd > −60 mV), blue—moderate dipole-modifying efficiency (−60 ≥ Δφd > −100 mV), and dark blue—significant decrease in φd (Δφd ≤ −100 mV).
Biomolecules 16 00342 g013
Figure 14. The relationship between the structure of chromonylallylmorpholines (a,b) and their dipole-modifying ability. The logD, μ, and Δφd values are presented according to [244].
Figure 14. The relationship between the structure of chromonylallylmorpholines (a,b) and their dipole-modifying ability. The logD, μ, and Δφd values are presented according to [244].
Biomolecules 16 00342 g014
Figure 15. The effect of azoles on the dipole potential of phosphocholine membranes is explored. The mean maximum changes in the dipole potential (Δφd) are taken from [251]. The deviation from the mean Δφd value observed in experiments is presented as an error bar. The color of the column depends on the strength of the dipole-modifying ability of the compound: black—negligible effect on φd (|Δφd| < 20 mV), cyan—slight decrease in φd (−20 ≥ Δφd > −60 mV), blue—moderate dipole-modifying efficiency (−60 ≥ Δφd > −100 mV), and dark blue—significant decrease in φd (Δφd ≤ −100 mV). Inset—the chemical structure of N’-(3,5-difluorophenyl)-benzenecarbothiohydrazide.
Figure 15. The effect of azoles on the dipole potential of phosphocholine membranes is explored. The mean maximum changes in the dipole potential (Δφd) are taken from [251]. The deviation from the mean Δφd value observed in experiments is presented as an error bar. The color of the column depends on the strength of the dipole-modifying ability of the compound: black—negligible effect on φd (|Δφd| < 20 mV), cyan—slight decrease in φd (−20 ≥ Δφd > −60 mV), blue—moderate dipole-modifying efficiency (−60 ≥ Δφd > −100 mV), and dark blue—significant decrease in φd (Δφd ≤ −100 mV). Inset—the chemical structure of N’-(3,5-difluorophenyl)-benzenecarbothiohydrazide.
Biomolecules 16 00342 g015
Figure 16. Classification of small molecules according to their dipole-modifying ability.
Figure 16. Classification of small molecules according to their dipole-modifying ability.
Biomolecules 16 00342 g016
Figure 17. The molecular characteristics of the most effective dipole modifiers, their influence on various parameters of the dipalmitoylphosphocholine melting endotherm, and their potential localization within the membrane have been analyzed based on the classification system provided by Jain and Wu [256] (type*). The terms μ, logD, ΔTm, ΔT1/2, ∆∆Hcal represent the molecular dipole moment, the logarithm of the octanol/water partition coefficient, changes in the main phase transition temperature, alterations in the half-width of the main peak, and variations in the enthalpy of dipalmitoylphosphocholine’s main phase transition. Data on the melting endotherm parameters of dipalmitoylphosphocholine in the presence of these dipole modifiers were compiled from studies [93,94,151,244,251,253,254,255]. Amphiphiles classified as types A, B, C, and D/E are proposed to localize in distinct regions of the membrane: specifically, near the C1–C9 atoms of hydrocarbon chains, the glycerol backbone, the C9–C16 portion of acyl chains in membrane lipids, and in proximity to the phosphocholine residues, respectively.
Figure 17. The molecular characteristics of the most effective dipole modifiers, their influence on various parameters of the dipalmitoylphosphocholine melting endotherm, and their potential localization within the membrane have been analyzed based on the classification system provided by Jain and Wu [256] (type*). The terms μ, logD, ΔTm, ΔT1/2, ∆∆Hcal represent the molecular dipole moment, the logarithm of the octanol/water partition coefficient, changes in the main phase transition temperature, alterations in the half-width of the main peak, and variations in the enthalpy of dipalmitoylphosphocholine’s main phase transition. Data on the melting endotherm parameters of dipalmitoylphosphocholine in the presence of these dipole modifiers were compiled from studies [93,94,151,244,251,253,254,255]. Amphiphiles classified as types A, B, C, and D/E are proposed to localize in distinct regions of the membrane: specifically, near the C1–C9 atoms of hydrocarbon chains, the glycerol backbone, the C9–C16 portion of acyl chains in membrane lipids, and in proximity to the phosphocholine residues, respectively.
Biomolecules 16 00342 g017
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Efimova, S.S.; Pham, Q.M.; Trinh, H.T.T.; Pham, L.Q.; Ostroumova, O.S. Alteration of Lipid Bilayer Electrical Potential by Phytochemicals and Synthetic Analogs: Implications for Cellular Function. Biomolecules 2026, 16, 342. https://doi.org/10.3390/biom16030342

AMA Style

Efimova SS, Pham QM, Trinh HTT, Pham LQ, Ostroumova OS. Alteration of Lipid Bilayer Electrical Potential by Phytochemicals and Synthetic Analogs: Implications for Cellular Function. Biomolecules. 2026; 16(3):342. https://doi.org/10.3390/biom16030342

Chicago/Turabian Style

Efimova, Svetlana S., Quan Minh Pham, Huong Thi Thu Trinh, Long Quoc Pham, and Olga S. Ostroumova. 2026. "Alteration of Lipid Bilayer Electrical Potential by Phytochemicals and Synthetic Analogs: Implications for Cellular Function" Biomolecules 16, no. 3: 342. https://doi.org/10.3390/biom16030342

APA Style

Efimova, S. S., Pham, Q. M., Trinh, H. T. T., Pham, L. Q., & Ostroumova, O. S. (2026). Alteration of Lipid Bilayer Electrical Potential by Phytochemicals and Synthetic Analogs: Implications for Cellular Function. Biomolecules, 16(3), 342. https://doi.org/10.3390/biom16030342

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop